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Listeria monocytogenes (L.m.) is a food-borne bacterium that can cause severe disease. 
Nevertheless, recombinant L.m. have been developed as potential vaccine vectors. Due 
to the importance of the mucosal immune system and the requirement for developing 
vaccine therapies for cancer and detrimental infections, this thesis focuses on the 
analysis of innate and adaptive immune responses to intravenous or oral L.m. infection. 
Costimulation molecules are essential for optimal CD8 T cell responses against L.m. 
infection. PD-L1 is an important negative regulator of T cell immune responses via 
interactions with PD-1 and CD80. However, PD-L1 can also act as a positive 
costimulator, but the factors determining its effect on activation are unknown. We found 
that PD-L1 provided costimulation to antigen-specific CD8 T cells independent of CD4 T 
cell help in response to L.m., but not to Vesicular stomatitis virus infection. Specific 
blockade of PD-L1 binding to CD80 or/and PD-1 did not recapitulate the effect of a 
general blockade of PD-L1. The results suggested that PD-L1 plays an important 
costimulatory role for antigen-specific CD8 T cells during L.m. infection through a 
distinct receptor or interaction epitope. 
 
In addition, as the natural infection route for L.m. is through ingestion of contaminated 
food, we also studied the immune response to oral L.m. infection using a murinized L.m.. 
Initially, infection was limited to the gut mucosa. Intracellular L.m. was initially shuttled 
through the subcapsular sinus into the interfollicular zones of the mesenteric lymph  
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nodes(MLNs) and subsequently appeared in the T cell zone.  In response, an organized 
cellular architecture rapidly developed in which Ly6G+ neutrophils initially surrounded 
L.m., followed by formation of an outer zone of CD103+ dendritic cells (DCs) and T cells, 
indicating a potential antigen presentation site. Dissemination of both L.m. and 
irradiated L.m., but not Salmonella, to the MLNs required Batf3-dependent DCs, 
suggesting the existence of a receptor-mediated pathway for L.m. acquisition, rather 
than provision of a replicative niche.  In sum, our data characterized the organization of 
innate immune responses to an orchestrated Listeria dissemination pattern in the gut 
mucosa.  
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CHAPTER 1 
 
INTRODUCTION 
 
The gut mucosal system is constantly exposed to a large collection of microbes. 
Microbiota are critical for the homeostasis of mucosal immune responses1-3. 
Inflammatory diseases like IBD, and even rheumatoid arthritis are associated with 
gastrointestinal infection4,5. Due to the importance of microbiota and intestinal mucosa, 
extensive studies on intestinal mucosal immunology are needed. Listeria 
monocytogenes (L.m.) is saprophytic bacterium that is usually transmitted to humans 
through contaminated food5.  L.m. can cause severe disease including meningitis and 
spontaneous abortion and is particularly deleterious in aged and immune-compromised 
individuals6,7, with a mortality rate of approximately 20%8. Both innate and adaptive 
immunity are required for protection against Listeria infection. Nevertheless, 
recombinant L.m. are being developed as potential vaccine vectors for cancer or 
infection diseases due to its ability to initiate robust immune responses and easy-to-
manipulated genes. Due to the importance of the mucosal immune system and the 
need for vaccine therapies for cancer and detrimental infections, this thesis is focusing 
on the analysis of innate and adaptive immune responses after intravenous or oral 
infection by Listeria monocytogenes. 
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I. Listeria monocytogenes 
A. Listeria monocytogenes 
L.m. is facultative, rod-shaped Gram-positive bacterium and cause Listeriosis 
contracted by consuming contaminated food. Listeria is termed after a sterile 
surgery Joseph Lister in 1940. The L.m. bacterium is 0.5 µm in width and 1–1.5 µm in 
length9,10. It is able to survive and replicate both in soil and cytosol of eukaryotic host 
cells. L.m. can overcome extreme environments such as high salt, low temperature, and 
wide pH ranges. Thus, L.m. thrives in various habitats, and refrigerated food storage 
does not prevent L.m. from contaminating foods9,10. The primary infection route is via 
crossing the intestinal epithelium after consumption of contaminated food. It can cause 
severe disease to immune-compromised individuals and spontaneous abortion of 
pregnant women. The outbreak frequency is 2.4/year on average and the death rate 
among the illnesses is around 20% according to CDC statistics8. Although the outbreak 
rate is not as high as other epidemic diseases, it is life threatening for newborns and old 
people. On the bright side, L.m. induces efficient immune responses, thus recombinant 
L.m. have been designed to carry cancer or virus antigens to trigger host PAMP 
sensors and elicit robust antigen-specific cytotoxic CD8 T cell responses. Attenuated 
L.m. strains have been developed as potential immunotherapies for cancer and other 
infections including HIV infection11-13. 
 
B. Advantages of the L.m. infection model for the study of immune responses 
George Mackaness developed the first systemic L.m. infection mouse model in the 
1960s14. Immunology studies have benefited significantly from the analysis of the 
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murine model of L.m. infection. There are several advantages to using L.m. as a tool to 
study immunology, including: 1) The life cycle of L.m. has been well studied, and L.m. 
replicates efficiently in the cytosol of host cells in vivo9; 2) L.m. elicits robust CD4 T and 
CD8 T cell responses15; 3) Antigen-specific T cells form memory after primary infection, 
and provide efficient life-long protection against secondary infection15; 4) Dominant 
protective epitopes for CD4 T cells and CD8 T cells have been identified in B6 and 
Balb/c mice, which provides a convenient tool to study antigen-specific T cell 
responses16; 5) L.m. is an easy-to-engineer bacteria strain: antigen epitopes can be 
engineered into the recombinant L.m., including epitopes from other pathogens, like 
GP33-41 for LCMV17, and HA518-526 for influenza18, etc.. Thus, these characters make L.m. 
not only an excellent tool to study multiple antigen-specific immune responses but also 
make L.m. a promising candidate for vaccine vector11; 6) The strength and duration of 
L.m. infection can be adjusted according to the needs of the study by treatments with 
antibiotics, or by using attenuated L.m. in which genes important for virulence have 
been deleted, such as Act-A--L.m. or LLO--L.m.. These attenuated strains are very 
useful to study critical molecules involved in immune protection, like INFγ, as mice 
deficient for these genes are susceptible to death with wild type L.m. infection even 
when infected with a very low dose19; 7) as a food-borne bacterium, the primary 
infection route for L.m. is by ingestion of contaminated food. Following 
gastrointestinal infection, L.m. induces efficient local immune responses and generates 
protective mucosal T cell memory. As memory is the foundation for vaccination, L.m. 
serves as an optimal vaccine vector for the development of mucosal vaccines11,20, and 
knowledge obtained from L.m. oral infection could provide valuable comparisons for 
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studying immunity in other mucosal tissues such as lung; 8) L.m. infects various non-
phagocytic cells, and it actively crosses intestinal barrier. Instead, the non-enteric 
bacteria such as Enterrococcus faecalis21 requires pre-treatment with antibiotics mix to 
allow bacteria traverse through intestinal barrier. Thus, less intervention is needed 
during infection compared with non-enteric bacteria. Taking together, with these 
advantages, L.m. serves as an excellent tool to study antigen-specific T cell responses 
and intestinal mucosal immune responses. 
 
II. L.m. clearance and subsequent immune responses following i.v. infection 
A. L.m. dissemination from blood stream to spleen 
In the L.m. i.v. infection mouse model, systemic infection is established by intravenously 
injection of L.m. into the bloodstream14. Once entering the blood stream, L.m. are 
quickly phagocytosed by various myeloid cells, including neutrophils, dendritic cells and 
macrophages22. Some of the L.m. in blood form complexes with complement C3 and 
platelets. As a result, those bacteria can avoid phagocytosis by macrophages in blood, 
and disseminate to the red pulp (RP)/marginal zone of the spleen to initiate immune 
responses23.  In spleen, the marginal zone of the white pulp contains macrophages, 
CD8α+ dendritic cells (DCs) and neutrophils, all of which have been shown to 
phagocytose L.m. following i.v. infection22,24. However, L.m. predominantly accumulates 
in CD8α+ DCs instead of other cells within 15hrs after i.v. infection22,25. After acquisition 
of L.m., CD8α+ DCs migrate from the marginal zone to the T cell zone26. Thus, during 
L.m. infection, DCs not only serve to present antigen to prime T cell response, but also 
play an important role by providing a cellular niche and facilitating L.m. dissemination. 
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B. Innate immunity to L.m. infection 
In the L.m. i.v. infection mice model, normally L.m. is cleared around day 10 after 
infection. Both innate and adaptive immune responses are required for the optimal 
clearance of L.m.14. The innate immune system quickly controls the initial wave of L.m. 
and prepares the adaptive immune system to completely clear bacteria, and provide 
sterilizing immunity.  
 
At the surface of host cell, L.m. is detected by TLR227. L.m.-derived lipoteichoic acid 
(LTA) binds to TLR2 homodimers. Mice are highly susceptible to infection with L.m. and 
some other Gram-positive bacteria infection in the absence of TLR2 signaling28,29. 
Meanwhile, CD14, which was discovered as an accessory molecule for TLR4, can also 
form heterodimers with TLR2 to sense L.m., and CD14 deficiency also leads to delayed 
L.m. clearance28. The role of TLR4 in L.m. infection has not been clarified.  L.m. are 
Gram+ bacterium, which does not have LPS as a component of the cell wall. However 
L.m. contains LPS-like structures that could potentially stimulate TLR430. Although L.m. 
express flagellin and purified flagellin from L.m. stimulates TLR5, TLR5 signaling is not 
required for L.m.-induced immune responses, as the TLR5 knockout mice clear bacteria 
normally31. Flagellin expression ceases at 37°C in L.m., which may partially explain the 
normal bacteria clearance in TLR5 knockout mice31. Nevertheless, Myd88, through 
which TLRs signal, is required for L.m. clearance32.  
 
L.m. uses listeriolysin (LLO), a pore-forming protein, to escape from the phagosome to 
the cytosol. L.m. invading into the cytosol is required for optimal DCs activation, T cell 
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priming and long-term protection to secondary infection33,34, as L.m. stimulates multiple 
pattern recognition receptors and inflammasomes in the cytosol, including NOD1, NOD2, 
NALP3 and lpaf35. The LLO molecule is also directly associated with caspase-1 
activation, as it is irreplaceable by molecules with similar function and structure36. 
Cytosolic signaling leads to NF-κB nuclear translocation and p38 MAPK 
phosphorylation37. Retaining L.m. in the phagosome induces the immunomodulatory 
cytokine, IL-1038. Compared to vacuolar L.m., which only leads to MyD88-dependent 
signaling, cytosol L.m. stimulates IRF3-dependent transcription, including of IFNβ35. 
NALPs and lpaf forms inflammasomes to activate caspase-1-dependent production and 
maturation of IL-1β and IL-18. Caspase-1 activation is also required for L.m. clearance39. 
IL-1β and IL-18 synergizes to attract leukocytes clustering around L.m. foci40.  The 
CCR2+Ly6C+ inflammatory monocytes in the cluster are required for optimal L.m. 
clearance following i.v. L.m. infection, because CCR2+Ly6C+ inflammatory monocytes 
differentiate to iNOS-producing dendritic cells (TipDCs)41. Instead, neutrophils are 
dispensable for bacteria clearance in spleen unless a lethal dose of L.m. is injected41,42, 
but for bacteria clearance in liver, neutrophils are required42. The IL-17/IL-23 axis plays 
important role in attracting neutrophil migration into liver43. Besides TipDCs, NK cells 
and macrophages also contribute to the optimal clearance of L.m. NK cells serve as 
early INFγ producers, stimulated by IL-18 to initiate subsequent immune responses 
against L.m. invasion. NK cell clustering is dependent on CD8α+ DCs acquisition of L.m.. 
However, either NK cell or neutrophil seems dispensable for cluster formation in 
response to infection40. Not only hematopoietic cells, astrocytes, and fibroblasts are also 
shown to contribute to L.m. clearance, which is mediated by NOD1 signaling44. 
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C. Adaptive immunity to L.m. infection 
The innate immunity to L.m. infection plays important roles in controlling early infection. 
However, to sterilize the infection, the adaptive immunity is required. Either MHCI or 
MHCII deficiency impairs L.m. clearance, thus CD4 T cells and CD8 T cells are required 
for complete L.m. clearance45-47. L.m. infection generates memory T cells that provide 
life-long protection for the secondary infection, and provides foundation for the 
development of L.m. based vaccine. In contrast to the impact of T cell response, wild 
type L.m. escapes from host humoral protection. This is because L.m. replicates in the 
cytosol of infected cell, and escape to the adjacent cells via actin-based mobility without 
traveling outside of cells9.  
 
CD8 T cell responses 
L.m. induce robust CD8 T cell responses. Spleen is the major antigen presentation site 
for T cell priming during systemic L.m. infection46,47. Soluble bacteria protein in the 
cytosol can be processed and presented by MHCI on the cell surface. Either antigen 
direct presentation, or cross-presentation efficiently primes antigen specific CD8 T cell 
responses during L.m. infection48,49. However, cross-presentation results in enhanced T 
cell priming compared to direct presentation49. Also, compared to non-secreted antigen, 
secreted antigen prime stronger CD8 T cell response50. Activated CD8 T cell 
differentiated to Tc1 CTLs secret cytokines including INFγ and TNF, efficiently clear 
L.m., and kill L.m. infected cells. The expansion of antigen specific CD8 T cell is 
influenced by the initial infection dose and the duration of pathogen persistence51. The 
peak of the antigen specific CD8 T cell response is around day 8 following i.v. infection. 
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Contraction happens around day 10 after infection. Different from expansion of the CD8 
T cells, the timing and extend of contraction is not related to the dose and persistence of 
pathogen51.  
 
CD8 T cell memory 
Immune memory is a hallmark for the adaptive immune system and it is the foundation 
for vaccine development. L.m. infection generates memory T cells that provide life-long 
protection against secondary infection. LLO- or ActA-deficient L.m. still generates potent 
memory responses50,52. This is beneficial for the development T cell vaccine using 
attenuated L.m., and the attenuated strains have been shown to successfully initiate 
protective responses in infections and cancer models13. Effector T cell heterogeneity is 
a hallmark of CD8 T cell responses to infections53. Based on KLRG1 and IL-7R 
expression levels, four populations of effector cells can be identified: early effector cells 
(KLRG1- IL-7R-; EEC) that give rise to the other subsets and have the greatest 
development potential compared to other subsets54, short-lived effector cells (KLRG1+ 
IL-7R-; SLEC) that do not survive long-term, memory precursor effector cells (KLRG1- 
IL-7R+; MPEC) that survive to form the memory pool, and double positive effector cells 
(KLRG1+ IL-7R+; DPEC) whose origin is unclear55-57.  
 
A single naïve CD8 cell can develop to different effector lineages after infection58. The 
differentiation of SLEC occurs during CD8 T cell priming57,59, and requires signal from 
both TCR and related cytokines59-62. IL-2 and IL-12 induces SLEC differentiation by 
affecting the expression of transcription factors including T-bet, Blimp1, Eomes, and 
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Bcl6. IL-2 enhances Blimp-1 and suppresses Bcl-6 expression63. IL-12 induces T-bet 
expression while repressing Eomes64. Besides, IL-27 and type I interferon also drives 
SLEC formation54,55. Expression of T-bet and Blimp1 facilitates SLEC differentiation 
while Eomes and Bcl6 modulate MPEC formation57,63,65. Activation of mTOR pathway 
promotes T-bet expression versus Eomes and thus favors SLEC differentiation66.  
 
As cytokines affect the expression of the transcription factors including Eomes, Blimp1, 
Eomes and Bcl654,59,63,64, the differentiation of CD8 T cell precursor is sensitive to the 
inflammatory milieu. Thus, different infections lead to varied effector differentiation. 
During primary L.m. i.v.  infection, up to 70% of splenic OVA-specific CD8 T cells are 
SLEC on the peak of CD8 T cell responses (dpi8)54. However, only 30% of SLEC can 
be recovered from the spleen of VSV i.v. infected mice, as a result of  lower IL-12 
cytokine level compared L.m. infection54. Also, long-term memory of antigen specific 
CD8 T cells might be related to infection routes67.  
 
CD4 T cell responses 
L.m. infection also elicits robust CD4 T cell responses. CD4 T cell responses are also 
required for optimal L.m. clearance by providing helps to CD8 T cells, although CD4 
CTLs themselves without CD8 T cells fail to control bacteria titer in i.v. infection 
model59,68. The immunodominant CD4 T cell epitope in B6 mice is LLO190-20169. A recent 
report proposed that the differentiation of CD4 T cell is related to infection route, using 
L.m. i.v. infection compared with L.m. intranasal infection67. In this study, i.v. infection 
generates Th1 effector cells while intranasal infection generates Th17 effectors, and 
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Th1 cells survive longer than Th17 cells as a result of higher expression levels of Bcl2, 
IL-15 receptor and CD2767. After infection, activated CD4 T cells differentiate to Th1 
cells under IL-12 milieu and produce cytokines contributing to the clearance of 
bacteria70. The expansion of antigen specific CD4 T cells occurrs synchronously with 
the CD8 T cell expansion during L.m. i.v. infection71. As with CD8 T effector cells, the 
distribution of CD4+ effector cells is dependent on the infection route. For i.v. infection, 
most of antigen specific CD4 T cells are located in liver and spleen. For oral infection, 
antigen specific CD4 T cells are predominantly in Lamia propria (LP), intestinal 
epithelium and liver72.  
 
CD4 T cells provide helps to both primary and secondary CD8 T cell responses73,74. 
CD4 T cell helps CD8 T cell responses can be mediated by CD40:CD40L interaction75,76. 
For L.m. i.v. infection, CD4 T cell help  is required for both primary and secondary CD8 
T cell response, although the generation of functional memory CD8 T cells are not CD4 
T cell dependent. The requirement for CD4 T cells is correlated but independent of 
CD40:CD40L interaction. The CD8 T cell responses in response to L.m. also require 4-
1BB:4-1BB-L, and CD28:CD80 costimulation77. Meanwhile, CD4 T cells provide help to 
effector CD8 T cell differentiation mediated by the IL-2 and CD25 axis59.  
 
CD4+-T cell memory 
Different from their CD8+ counterparts, the IL-7R and KLRG1 combination theory does 
not predict CD4 T cell memory precursor identity78, and the phenotype of CD4 T cell 
memory precursor has not been clarified. Studies about CD4 T memory cells proposed 
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different markers describing the memory precursor in different infection models. The 
expression profile of PSGL-1hiT-betintLy6Clo is proposed recently for CD4 T cell memory 
precursor in LCMV i.p. infection78. Meanwhile, CD47, a receptor for signal regulatory 
protein α and thrombospondin-1, also proposed to predict CD4 T memory precursor in a 
OVA-immunization mice model79.  
 
D. Strategies L.m. uses to escape from host immunity 
Besides intracellular spreading mediated by actA, L.m. employ other mechanisms to 
escape from immune surveillance. Epigenetic histones modification, including 
phosphorylation and acetylation etc., exposes DNA motifs in chromatin to transcription 
factors80. However, after L.m. infection, LLO induce dephosphorylation of host histones, 
thus inhibits the transcription of genes that TLR2 signaling activates81,82. L.m. can 
deacetylate its own peptidoglycan in the cell wall to avoid TLR2 and NOD1 signaling, 
mediated by a N-deacetylase gene, pgdA83. pgdA mutants enhances NODs dependent 
NF-κB activation compared with wild type L.m.83. Autophagy is a self-degradation 
mechanism mediated by lysosome digestion to remove unnecessary or dysfunctional 
cellular components84. It also serves as a host defense mechanism against intracellular 
pathogens. However, actin-based motility and bacterial phospholipase C allows L.m. 
escape from autophagy and LLO inhibits the maturation of L.m. containing 
phagosomes85. LLO also induces apoptosis of lymphocytes. During infection with LLO-
deficient L.m. or when infected mice are treated with anti-LLO mAB, there is significantly 
reduced lymphocyte apoptosis induced by L.m86-88. The LLO-induced lymphocytes 
apoptosis during the early infection stage is dependent on caspase activation, type I 
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interferon, and granzyme B86,87,89,90. Thus, IFNAR deficient mice are actually more 
resistant to L.m. infection, which can also caused by the suppression of IFNγ induced 
macrophages activation by Type I interferon, as these macrophages are also important 
for bacterial clearance.89,91. Also, deficiency of the X-linked inhibitor of apoptosis (XIAP) 
decreases survival of L.m. infected mice and delayed bacteria clearance92.  
 
III. Vascular stomatitis virus  
Another pathogen that has been used extensively to study immune response is 
vesicular stomatitis virus (VSV). VSV is a bullet shaped, single-stranded, negative 
sense RNA virus, which encodes five proteins: N, L, P, M, and G93,94. VSV belongs to 
the Rhabdoviridae family. There are two major wild type VSV serotypes, Indiana and 
New Jersey (VSV-IND and VSV-NJ)93. When administered intracranially or intranasally, 
VSV infection can cause severe neurotoxicity in rodents93. Nevertheless, it has been 
extensively studied as a vaccine vector for infection and oncolytic virus therapy, due to 
its ability to induce robust adaptive immune responses95,96. While neutralizing antibody 
is most critical for protection against VSV infection, substantial CD4 and CD8 T cells 
responses are induced by VSV infection. 
 
Expression of type I interferon and nitric oxide quickly controls VSV replication97,98, 
which are initiated by pattern recognition receptors including TLR 4, 7, 13 etc.99-102. 
Following VSV infection, CD4 T cells are required for optimal antibody protection 
mediated by the CD40L/CD40 axis103, and humoral responses are critical and protective 
for VSV infection96. VSV-N(RGYVYQGL) is the immunodominant epitope for CD8 T cell 
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response following VSV infection of C57BL/6 mice104, and class I tetramers are 
available to identify endogenos N-specific CD8 T  cells. Different from L.m. infection, 
VSV infection leads to less IL-12 production, and thus significantly reduces production 
short-lived effector CD8 T cells54. On day 8 after VSV infection in mice, 50% of the 
IgG2a antibody-producing cells are VSV specific105. Meanwhile, draining lymph node B 
cells play important role in the maintenance of subcapsular sinus (SCS) macrophages, 
which serve to limit invasion of virus106. 
 
IV. Three signals for T cell activation  
A. T cell activation 
Antigen specific CD8 T cells are activated after the interaction between TCR expressed 
on T cells and cognate peptide-MHCI complex on antigen presenting cells107. MHCI is 
universally expressed on all the nucleated cells. Different from MHCII, MHCI associates 
with beta2-microglobulin forming deep groove that fits peptide epitopes 8-11 amino 
acids in length108. Dendritic cells are professional antigen-presenting cells, capable of 
both direct presentation and cross-presentation. Optimal T cell activation requires three 
signals: 1) interaction between TCR and the cognate peptide-MHC complex109, 2)  
positive costimulation to T cells to promote expansion and survival of antigen (Ag) 
specific T cells110,111; and 3) cytokines, as the third signal, facilitating T cell 
differentiation, expansion, and survival112. 
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B. Costimulation 
TCR recognition without costimulation signal leads to T cell anergy.  Anergic T cells are 
functionally inactive but can be long-lived for certain periods of time before becoming 
apoptotic110. B7 family molecules include, CD80(B7-1) and CD86(B7-2).  B7:CD28 
interactions provide critical costimulatory signals by: enhancing IL-2 production, and by 
enhancing TCR signaling by facilitating tyrosine kinase activation. Expression of 
costimulatory molecules increases quickly after infection and declines after day 3 or 4 
during acute infection111. Interestingly, the expression profile of different costimulatory 
molecules is quite alike. The alteration of expression level during infection is important 
to maintain T cell homeostasis by providing sufficient signaling to drive the responses 
needed for the elimination of pathogens, while then limiting unnecessary signaling to 
prevent detrimental impacts. The costimulatory system is highly redundant as a 
mechanism to protect host against pathogens. Blocking of costimulatory signals inhibit 
undesirable inflammation, and activation of costimulatory signals enhance immune 
responses. Tuning of the costimulatory axis is one of the critical methods to study 
potential immune therapies for infection and cancer. 
 
CD28-CD80/CD86 
CD28 is a type I membrane glycoprotein, expressed on T cells. CD80 (B7-1) and CD86 
(B7-2) are expressed on antigen presenting cells (APCs) and are upregulated upon 
activation. Among different pairs of costimulatory molecules, B7:CD28 is the most 
classic example and extensively studied. CD80 and CD86 are two identified ligands 
binding to CD28 transducing stimulatory signals by activation of PI3K113,114. CTLA-4 is a 
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structural homolog of CD28, and is expressed by activated T cells and regulatory T cell. 
CTLA-4 competes with CD28 binding to CD80 and CD86 with higher affinity, and serves 
as an inhibitory receptor to counteract costimulatory signals115. After infection, activation 
of pattern recognition receptors (PRRs) leads to an up-regulation of different 
costimulatory molecules including CD28:CD80/CD86116. CD4 T cells can form positive 
feedback to DCs activation by upregulating CD80 and CD86 expression level mediated 
by CD40:CD40L interaction77. In CD28 knockout mice, L.m. clearance is delayed as a 
result of impaired CD4 T and CD8 T cell activation and reduced antigen specific CD4 T 
and CD8 T effector cells77. Meanwhile, costimulation is required for not only T cell 
effector cell activation but also required for the optimal function of regulatory T cells117. 
 
CD40-CD40L 
CD40 and CD40L are glycoproteins belonging to the TNFR/TNF family. CD40 is 
expressed on various antigen presenting cells including DCs and macrophages. Its 
ligand CD40L (CD154) is upregulated upon T cell activation118. CD40 signaling in DCs 
enhances cytokine production induced by PRRs, and upregulates the expression of 
other costimulatory molecules including CD80 and CD86. L.m. infection enhances 
CD40 expression on antigen presenting cells and TipDCs, which are required for L.m. 
clearance. Also, CD40:CD40L axis is required for optimal secondary antigen-specific 
CD8 T cell responses74. For LCMV infection, CD40L deficiency impairs humoral 
responses as a result of interrupted T cell and B cell interaction, but the T cell response 
itself is not compromised119. For VSV infection, in the absence of CD40 signaling, the 
antigen-specific CD4 T cell response is impaired, and the corresponding CD8 T cell 
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response is also defective120. CD40:CD40L interaction also plays important roles in 
autoimmune diseases. CD40 signaling facilitates Th17 differentiation121. Deficiency of 
the CD40 signaling attenuates corresponding T cell responses and the development of 
autoimmune diseases122,123. On the other hand, anti-CD40L agonist mAbs are known to 
enhance T cell responses for tumor/cancer therapy124. 
 
OX40-OX40L and 4-1BB-4-BBL 
In addition to CD40:CD40L and B7:CD28, the APC:T cell interaction involves other pairs 
of costimulatory molecules, including 4-1BB:4-1BBL and OX40:OX40L. OX40 and 4-
1BB are costimulatory molecules belonging to the TNFR family. Costimulatory 
molecules in the TNFR family facilitate T cell activation through TRAF instead of TCR 
signal amplification125. OX40 or 4-1BB forms homotrimers when assembled on the cell 
surface126,127. OX40 and 4-1BB are associated with the development and severity of 
autoimmune diseases122,128-131. OX40 expression is higher on activated CD4 T cells 
while 4-1BB is expressed at higher levels by activated CD8 T cells132. Costimulation 
from OX40 and 4-1BB contributes to the expansion and survival of effector T cells. 
Compatible with their expression profile, OX40:OX40L costimulation plays an important 
role in CD4 T cell priming, differentiation and memory generation133, while 4-1BB:4-
1BBL preferentially costimulates CD8 T cells134. In the steady state, OX40 is expressed 
on regulatory T cells, and OX40 signaling on Treg activates Akt, and reduced 
suppressor ability135. 
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In the absence of OX40 signaling, mice fail to control chronic (Clone 13) LCMV infection 
as a result of reduced CD4 T cell responses due to impaired T cell survival136. In 
addition to its critical function in CD4 T cells, OX40 also plays important role in CD8 T 
cell memory commitment during Listeria infection137. During primary L.m. i.v. infection, 
antigen specific CD8 T cell expansion and function is not affected in the absence of 
OX40 signaling138. However, the frequency of KLRG1loIL-7Rhi memory effector 
precursors during primary infection is reduced when OX40 signaling is only absent in 
CD8 T cells. Also, OX40 signaling is essential for the survival of KLRG1loIL-7Rhi 
memory precursors. As a result, there is impaired memory formation when OX40 is 
deficient during L.m. infection138.  
 
4-1BB:4-1BBL interaction plays important roles in immune responses against infection 
and tumor. Different from CD40:CD40L signaling, 4-1BB:4-BBL interaction could lead to 
CD28:B7 independent costimulation77,139. During L.m. i.v. infection of 4-1BB knockout 
mice, CD8 activation is impaired, and the antigen-specific CD8 T cell population is 
reduced compared with wild type controls77. Administration of anti-OX40 agonist mAb 
simultaneously with anti-4-1BB agonist mAB facilitates granzyme B expression in CD4 
T cells and augments granzyme B expression in CD8 effector cells, induces tumor 
rejection and improves survival in a tumor model140-143. 
 
CD27-CD70 
Like CD40, OX40 and 4-1BB, CD27 also belongs to the TNFR family. CD27 is 
expressed as a transmembrane homodimer on T cells and its ligand CD70 is expressed 
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on APCs144. After infection, CD27 signaling is critical for T cell expansion and survival 
and long-term memory144,145. Higher expression of CD27 is related to better memory 
phenotype67. Although the expression of CD70 is normally transient and upregulated 
after activation, a subset of APCs in the intestinal LP constitutively expresses CD70 and 
is required for the priming and differentiation of intestinal T cells after L.m. oral 
infection146. 
 
C. Cytokines as the 3rd signal for T cell activation 
The role of cytokines during T cell activation can be summarized as: 1) “cytokine” 
costimulation; 2) promoting the survival of activated T cells 3) enhancing proliferation of 
the activated T cells112. In vitro assays showed that in the presence of MHCI and 
antigen while in the absence of costimulatory molecules, T cell anergy can be rescued 
by adding IL-1 and IL-6 in combination into the system110,147,148. In addition, anergy 
induced by CTLA-4 blocking of CD28 signaling can be reversed by addition of IL-2149,150. 
The common cytokine-receptor γ-chain (γc)-cytokines including IL-2, IL-15, and IL-7 are 
critical for maintaining T cell homeostasis. IL-2 is important for T cell proliferation, while 
IL-7 and IL-15 play important roles in long-term survival112,151,152. During the T cell 
activation process, activated T cells differentiate to distinct effector phenotypes 
according to the cytokine milieu. IL-12 shapes the CD4 T cell response toward Th1 and 
CD8 to Tc1 phenotype to produce TNF and IFNγ, while IL-4 differentiates T cells to Th2 
phenotypes, and IL-17 differentiates T cells to Th17 phenotypes152,153. Thus, the effector 
cell differentiation varies following infections with different pathogens or infection routes. 
For the studies of T effector cell differentiation and function, different infections or 
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infection routes need to be compared to dissect the mechanism. Moreover, for the 
benefits of vaccine development, cytokine environments could be manipulated to tune 
memory formation. 
 
V. The inhibitory role of PD-L1 in T cell 
Besides positive costimulation, there are coinhibitory signals crucial for maintaining 
immune system homeostasis109. The B7:CD28 co-stimulatory family consists of both 
positive costimulatory molecules (e.g. CD80/CD86: CD28) and negative regulators (e.g. 
CTLA-4:CD28, PD-L1/PD-L2: PD-1). The gene encoding programed dealth-1 (PD-1) 
was first isolated from a T-cell hybridoma cell line undergoing apoptosis, and it was 
found that PD-1 mRNA was upregulated when thymocytes death was enhanced by anti-
CD3 activation154. Moreover, PD-1 deficient mice developed lupus-like autoimmune 
diseases155. These findings suggested that PD-1 negatively regulated T cell activation.  
 
PD-1 overexpression dampens positive selection and PD-L1 deficiency increases 
numbers of CD4+CD8+ and CD4+ thymocytes population156. Thus, PD-L1:PD-1 
interaction suppresses positive selection and plays an important role in shaping naïve T 
cell repertoire. Inhibition of PD-1:PD-L1 interaction reverses T cell anergy and restore 
stable immunological synapses between T cells and antigen presenting cells157. PD-
1:PD-L1 signaling decreases T cell expansion and cytokine production by disrupting 
phosphorylation down stream of TCR signaling157,158,159. PD-1 signaling enhances 
phosphorylation of immunoreceptor tyrosine-based switch motif (ITSM) upon binding to 
its ligands, and the phosphorylation of ITSM recruits Src homology region 2 domain 
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containing phosphatase-1 (SHP-1) and SHP-2160. As a result, early TCR signals are 
attenuated by dephosphorylating Akt, PI(3)K, Zap70 and PKCθ161. PD-1 interaction with 
PD-L1 enhances pro-apoptotic molecule Bim expression in CD8 T effector cells during 
chronic infection and thus leads to increased apoptosis and reduced survival of CD8 T 
cells162. 
 
PD-1 signaling contributes to T cell exhaustion during chronic infection and in a 
tolerance model163,164. The inhibitory signal from PD-L1:PD-1 axis is one of the key 
mechanisms for T cell exhaustion. PD-1 preferentially upregulates on exhausted T cells 
induced by chronic infections164. During chronic LCMV infection, blockade of PD-L1:PD-
1 interaction restores proliferation, cytokines level, and cytotoxicity of CD8 T cells in 
both lymphoid and non lymphoid tissues164. Moreover, a unique PD-1:PD-L1 
suppressive signal was shown on CD8 T cells in the absence of CD4 T cell help164.  
 
Meanwhile, PD-L1 is required for optimal regulatory T cell maturation and maintenance. 
DCs deficient for PD-L1 fails to convert iTreg, and PD-L1 increases and maintains 
Foxp3 expression in iTreg cells165. In addition, PD-L1 is required for the optimal 
suppressive function of iTreg cells165. 
 
Besides, a direct role in T cells, PD-L1:PD-1 interaction is important in the negative 
regulation of DCs function. Mice that are adoptive transferred with PD-1 deficient DCs 
are more resistant to lethal L.m. infection compared with the wild type counterpart. PD-1 
deficient DC produces significantly enhanced level of IL-12 and TNF. The enhanced 
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protection in mice transferred with PD-1 deficient DCs is independent of T and B cell 
help166.  
 
Besides PD-1, CD80 has been identified to be another binding partner of PD-L1, as 
there are additional inhibitory effects from PD-L1 on CD4 T cells deficient of PD1, CD28 
or/and CTLA-4167. Chemical cross-linking data indicates the molecular surface for 
CD80:PD-L1 interaction partially overlaps the CD80:CD28 and CD80:CTLA-4 
interface167. This conformation indicates a potential competition among CD28, CTLA-4 
and PD-L1 to interact with CD80. According to in vitro surface plasmon resonance data, 
the affinity of CD80:PD-L1 is higher than the affinity of CD80:CD28 but is lower than 
CD80:CTLA-4167. However, the physical level of the three binding partners of CD80 
within the interaction synapse could also affect the in vivo affinity. One of the important 
mechanisms underlying the suppression of T-cell activation is CTLA-4 competing with 
CD28 binding to CD80 or CD86. CTLA-4 blockade generates great anti-tumor 
effects167,168 and the human monoclonal antibody, ipilimumab is an FDA approved 
therapy for melanoma168,169. Recent studies also indicated that CD80:PD-L1 plays a 
crucial role in T cell tolerance, as specific  interruption of  CD80:PD-L1 interaction by an 
anti-PD-L1 mAb (43H12, independent of PD-1:PD-L1 blocking) effectively restored T-
cell proliferation and inhibited the induction of T-cell anergy170.  
 
VI. Costimulation from PD-L1 
Although studies of the CD80:PD-L1 axis and PD-1:PD-L1 axis have focused on the 
aspect of inhibitory effects on T-cell activation, PD-L1 has also been proposed to serve 
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as a positive costimulator. PD-L1 is required to generate functional Th1 cells in the 
primary response after Salmonella infection. PD-L1 deficiency in Salmonella infected 
mice causes impaired survival and delayed bacteria clearance due to lower Ag-specific 
antibody production and impaired Th1 differentiation and expansion171. In another 
system, PD-L1 blockade but not PD-L2 blockade dampens leukocyte infiltration and 
attenuates the development of colitis (colitis model: adoptive transfer of wild type T cells 
into SCID mice)172. In addition, PD-L1 agonist autoantibodies isolated from rheumatoid 
arthritis patients are able to enhance T cell activation173. Mover, administration of PD-L1 
antagonist antibody during acute L.m. infection reduces Ag-specific CD8 T cells, results 
in increased bacterial burden and renders mice susceptible to L.m. infection174,175. 
Meanwhile, PD-L1 on naïve T cells is required for T-cell conditioned dendritic cell 
maturation, as DC from PD-L1 knockout mice showed diminished level of CD80, CD86 
and CD40 following influenza intranasal infection176. Thus, although it is more 
extensively studied as negative regulator, PD-L1 can also mediate positive 
costimulation. The factors that determine the positive or negative effects of PD-L1 on 
immune responses are now known. 
 
VII. Architecture and function of spleen and lymph node 
A. Spleen 
Spleen and lymph node are a well-organized lymphoid organ play critical role during 
anti-microbial immune events. Spleen contains red pulp and multiple white pulps (Figure 
1). Red pulp is characterized by its unique venous system. It functions to filter the blood, 
remove old erythrocytes, recycle iron, and it is also a site where plasma cells produce 
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antibodies177. White pulp is the lymphoid sheath separated by red pulp177. The structure 
of white pulp closely resembles that of lymph node. The boundary between red pulp and 
white pulp is filled by marginal zone macrophages (MZM), which can be identified by 
expression of ERTR9177. Then there are IgMhigh marginal zone B cells in between MZM 
and marginal metallophilic macrophages (MMM) that can be marked by anti-CD169 
mAB177. Further inside, there are B cell follicles that can be identified by anti-B220 mAB, 
surrounding T cell zones, also known as the periarteriolar lymphoid sheath (PALS) that 
can be identified by anti-CD3e mAb177. B cell follicles are sites for activated B cell clonal 
expansion, class switching, somatic hypermutation, and interaction with follicular T 
cells177,178. T cell zone contains T cells and DCs and some bypassing B cells. 
CXCL13:CXCR5 axis is required for B cell localization in B cell follicles, and 
CXCL19/21:CCR7 axis is required for maintaining T cells in T cell zone177,179. The exit of 
lymphocytes is mediated via S1P1:S1P axis180 using bridging channels, which are often 
associated with the central arteriole177,179. (Figure 1) 
 
B. Lymph node 
Lymphocytes enter into lymph nodes via afferent lymphatic vessels and high endothelial 
venules (HEVs), while exiting using efferent lymphatic vessels. The area close to the 
efferent vessels is medulla, marked by high density of lyve-1+ lymphatic vessels. The 
region close to the afferent vessels is cortex, which contains multiple B cell follicles 
surrounded by cortical sinus composed of Lyve-1+ lymphatic vessels181. The 
interfollicular zones act as important site to initiate immune responses in draining lymph 
node40,182. It is the area for DC influx into lymph node, and has been reported as where 
24 	  	  
VSV, vaccinia virus and Pseudomonas aeruginosa enter into draining lymph nodes182-
184. Interfollicular zones normally contain some Lyve-1+ lymphatic vessels, but it has not 
been clarified whether those lymphatic vessels are connected to SCS or cortical 
sinus183. The area in between cortex and medulla is paracortex, which contains the T 
cell zone, loaded with T cells and DCs. Like white pulp of spleen, the periphery of the 
lymph node is circled by CD11b+CD169+F4/80- subcapsular sinus macrophages (SSMs), 
which locate on the floor of SCS183. During VSV infection, the SSMs is critical in 
controlling virus invasion by secreting type I interferons106,185. However the role of SSMs 
in mesenteric lymph nodes following oral infection have not been identified. (Figure 2) 
  
VIII. Gut mucosal system 
The surface area of the digestive tract is almost 200 times that of the skin186. The 
intestinal tract is a major route of pathogen entry. Intestinal barrier, composed by 
epithelial cells connected by tight junction proteins, microvilli, and mucin, is the first 
physical barrier providing defense against intestinal microorganisms187. Gut-associated 
lymphoid tissues (GALT) contain lamina propria (LP), Peyer’s patches (PPs), and 
isolated lymphoid follicles (ILF). Towards the lumen side, it is the outer mucus layer, 
where most of the microorganisms are constrained. Underneath the outer mucus layer 
is the inner mucus layer, where there are comparatively fewer microbes. The 
compartment underlying villous epithelium is LP, where macrophages, DCs, and 
lymphocytes are located. Paneth cells in the epithelial layer or DCs in LP could fetch 
non-invasive microorganisms in the inner mucus layer and translocate them to 
MLNs187,188. PPs are organized lymphoid tissues lying in the submucosal layer of 
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intestine wall187. Each PP comprises B cell follicles, a space called the subepithelial 
dome (SED) between the follicle associated epithelium (FAE) and B cell follicles, and 
intervening T-cell dependent areas (TDA)187. M cells in FAE, act to uptake microbes and 
antigens from the intestinal lumen into the SED to elicit immune responses. IgA 
secreted by the activated B cells in PP as well as MLNs will be transcytosed to the 
mucus layer, working together with lysozymes to hydrolyze carbohydrates in bacterial 
cell walls as a way to clear pathogens188. In mouse, the development of PP occurs from 
embryo day 15.5. Treatment of anti-IL7R mAb during on embryonic day 14.5 prevents 
the development of PPs while MLNs are normal189. Mice deficient of PPs showed 
normal antigen presentation and T cell activation following oral peptide immunization190. 
PPs are the primary antigen presentation site following Salmonella infection191, however 
the role of PP in L.m. dissemination and antigen presentation following oral infection 
has not been studied. Meanwhile, ILFs also contain M cells and resemble the structure 
as well as function of PP. But ILFs have only a single follicle normally comprised by B 
cells and some DCs187. ILFs still exist in PP-deficient mice generated by IL-7R mAb 
treatment, and could compensate to PP function in PP-deficient mice192. (Figure 3) 
 
IX. L.m. dissemination and related cellular events 
A. L.m. dissemination following i.v. infection 
During an i.v. infection, the major reservoirs for L.m. are spleen and liver, and L.m. 
thrives preferentially in the cytosol of macrophage and hepatocyte. The primary antigen-
presentation site for L.m. i.v. infection is spleen. TNF and iNOS producing dendritic cells 
(TipDCs) play critical role in L.m. clearance193. Meanwhile, T cell priming is not affected 
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when mice are deprived of TipDC in CCR2-/- knockout mice, indicating that TipDCs are 
not critical for T cell priming193. Two steps need to be accomplished to initiate the T cell 
response. First, antigen needs to be transported from the infected tissue to the T cell 
priming site, and second, antigen needs to be processed and presented to naïve T cells. 
Deletion of DCs using CD11cDTR mice blunts T cell responses as a result of impaired 
antigen delivery by DCs, although this result was originally interpreted as a result of 
impaired T cell priming in the absence of corresponding antigen presenting cells25. 
Meanwhile CD169+ (MOMA-1+) macrophages and ERTR9 marginal zone macrophages 
were also eliminated in these CD11cDTR mice194. L.m. in the blood is shuttled by the 
cooperation of platelets and the complement component C3 to the red pulp/marginal 
zone of spleen23. The requirement for C3 is independent of C3a receptor but related to 
C3b opsonization, as pre-deposition of C3b on L.m. before infection leads to enhanced 
CD8α+ DCs acquisition and L.m. burden in spleen23.  In the absence of DCs, the L.m. 
burden is not affected in the blood23, suggesting that the function of CD8α+ DCs is 
mainly involved in the spleen. CD8α+ DCs acquire platelet-associated L.m. by an 
unknown process, and shuttle them to periarteriolar lymphoid sheaths (PALS) of 
spleen26. By 24hpi, most of the bacteria disseminates to PALS25. The PALS of the 
spleen is the major antigen-presentation site after i.v. L.m. infection26.  
 
A basic leucine zipper transcription factor ATF-like 3 (Baft3) is predominantly highly 
expressed in conventional DCs but not other cells. The development of CD8α+ DCs is 
dependent on transcription factor Batf3. In steady state, CD8α+ DCs/CD11b-CD103+ 
DCs are absent in mice lacking Batf3195,196, while other DC, macrophages, B and T cells 
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remain intact196. Additionally, Batf3-dependent DCs are required for cross-presenting 
carcinoma antigen to prime cytotoxic T cells195. Baft3-/- mice are more susceptible 
during Toxoplasma gondii infection as a result of impaired IL-12 level197. However mice 
deficient for Baft3 are resistant to L.m. infection198. In spleen, CD8α+ DCs are resident 
DCs located in the marginal zone of the white pulp in the steady state, and are capable 
of migrating into PALS after infection26. At 30min to 6hrs after i.v. infection, L.m. is 
predominantly maintained in the red pulp and marginal zone of both wild type control 
mice and Baft3-/- mice198. But due to the absence of CD8α+ DCs in the marginal zone of 
the Baft3-/- mice, L.m. fails to disseminate to PALS26,198,199. At 48hr after infection, a 
reduction of CD8α+ DCs was detected suggesting a possibility of L.m.- induced cell 
death, although CD8α+ DCs containing L.m. can be successfully isolated from the 
splenocytes at these times26,198,199. Despite of the absence of CD8α+ DCs in the steady 
state and during acute infection, related AP1 factors, Batf and Batf2 are able 
compensate to the function of Batf3 after long-term infection mediated by IL-12 and 
IFNγ, such as during M. tuberculosis infection. Compensation among BATF factors is 
due to the shared leucine zipper domains, interacting with IRF4 and IRF8200.  Rac1, 
which is shown to be important for quantity and phagocytic quality of CD8α+ DCs, is 
involved in both lnlA and lnlB signaling pathways25. However, bacteria burden recovered 
from CD8α+ DCs is not affected when mice are infected with lnlA- and lnlB-deficient 
L.m..25, and L.m. maintenance in CD8α+ DCs during early i.v. infection does not require 
lnlA and lnlB. However it is still possible that other receptors could be involved in the 
process of CD8α+ DCs L.m. acquisition. Whether CD8α+ DCs are carriers, which 
preferentially recognize L.m. or only provides a growth niche for L.m. is unknown, and 
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how L.m. disseminates in gut mucosa and the antigen-presentation sites after oral 
infection has not yet been clarified. 
 
B. L.m. dissemination following oral infection 
In gut mucosa, L.m. crosses the intestinal barrier via M cell uptake into PPs or via 
human intestinal epithelial cell (IEC) invasion mediated by interaction between internalin 
A expressed on the surface of L.m. and E-cadherin expressed on host IEC. Human but 
not mouse E-cadherin binds well to L.m. internalin A. To optimize L.m. infection in 
mouse model, Schubert’s group designed a murinized L.m., expressing a mutant 
version of internalin A (lnlAm) that binds to mouse E-cadherin with similar affinity as its 
human counterpart201. Recent reports showed that the lnlAm-L.m. disseminates more 
efficiently than wild type L.m. to MLNs in mouse model following oral infection202. This 
murinized L.m. allows us to better investigate immune responses in intestinal mucosa 
with following oral infection in mouse model.  
 
How L.m. disseminates in gut mucosa and how the subsequent immune responses are 
induced following oral infection has not yet been clarified. Antigen presentation during 
Salmonella oral infection primarily occurs in PPs191. Different from Salmonella, L.m. 
crosses human intestinal barrier via both PP and IEC. As only human but not mouse E-
cadherin binds well to L.m. internalin A. We utilize murinized L.m. for oral infection to 
better investigate immune responses in the intestinal mucosa. Using signature-tagged 
L.m., a recent study demonstrates the L.m. dissemination route in guinea pigs203. Based 
on this study, intestinal villi provide a niche for L.m., as L.m. in lumen continually bind to 
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villi epithelium but shed back to the lumen instead of spreading from enterocytes to 
lamia propria. This proposal is based on their previous study204, in which they showed 
the basement membrane underlying the epithelium layer is very hard to penetrate and 
preventing cell-to-cell spread of bacteria. Finally, the L.m. shed from epithelium to 
lumen would be endocytosed by M cells into PPs. In the liver of 2 of 7 infected animals, 
L.m. can be detected by qPCR as early as 4hrs after oral infection. However, at 12hrs 
after oral infection, no L.m. can be detected, which was interpreted to be due to an early 
wave of L.m. clearance between 4 and12hrs. However, more animals need to be 
included to confirm this conclusion. Then, L.m. can be detected again around 24hr after 
infection. Different from liver, spleen is the last organ L.m. arrives in. Based on the 
variety of the tagged L.m. recovered from liver, the authors of the study proposed that: 
clones in liver may come from two routes: One is via the portal vein from small intestine, 
and the other route is via the systemic bloodstream. The authors also found a strong 
correlation between clones in spleen and MLNs as well as liver and MLNs, indicating 
that L.m. could travel to MLNs and then translocate from MLNs to liver or spleen. But 
the L.m. in liver was largely from the direct translocation from intestine following portal 
veins203. 
 
C. Migratory dendritic cells in gut mucosa 
In intestine, DCs are present in PPs, ILFs and lamina propria. Migration of DCs to MLNs 
occurs from the blood stream via HEV and from intestine, transmitted by afferent 
lymphatic vessels186. Migratory DCs have been studied based on two approaches: 
collection of DCs from afferent lymphatic vessels by cannulation, and sorting of DCs 
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according to their phenotypes. CCR7 is a hallmark for leukocyte migration to draining 
lymph nodes. In CCR7-/- mice, DCs are not able to migrate from periphery tissue to 
draining lymph node, as a result the volume of lymph nodes is significantly reduced in 
both steady state and after infection205,206. CD103 (αE integrin) has been shown as a 
trustworthy marker for migratory DCs from tissues207. Thus, DCs expressing CD103 
have been proposed to be migratory DCs, and were shown to be the case in skin, lung 
and intestinal mucosal tissues186.  
 
DCs in PPs 
In PPs, most of the DCs are CD11blo CD8α+ DEC-205+ based on flow cytometry 
analysis of collagenased-tissues208. Based on in situ staining analysis of PPs, most of 
the DCs in the SED are CD11b+ DCs, and CD11blo CD8α+ DCs are mostly located in the 
interfollicular zones (T cell area of PPs). All DCs subsets in PPs are CCR7+ and are 
able to further upregulate CCR7 after stimulation209. Only SED DCs are CCR6+, and 
CCR6 functions to maintain SED DCs in SED as the CCR6 ligand CCL20 (MIP-3 alpha) 
is expressed in SED209,210. After antigen (STAg) stimulation, SED DCs upregulate CCR7 
and migrate to interfollicular zones209. 
 
DCs in LP 
The majority of CD11chi DCs in LP are CD11b+ CD8α- DCs, while CD11b-CD8α- DCs, 
CD11b-CD8α+ DCs and double negative DCs also exist. In the steady state, 70% of the 
LP CD11chi DCs express CD103, and they are believed to be the DCs sampling 
antigens from intestine and migrating to MLNs211. They are CX3CR1 negative, and 
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promote IgA production. CD103+ DCs express higher level of RALDH2 that metabolizes 
retinal to retinoic acid, as a result they imprint T cells with a migratory phenotype and 
induce iTreg by secreting TGFβ212,213. It has been shown that CX3CR1+ DCs can 
extend their dendrites through the interval of intestinal epithelial cells to uptake antigens 
in the lumen (based on images from fixed frozen samples)214. However CX3CR1+ DCs 
were only shown to be required for the sampling of non-invasive pathogens214. 
CX3CR1+ DCs are CD103 negative and promote Th17 and colitis development. 
CX3CR1+ DCs have macrophage features, e.g. they express F4/80 and CD11b, and 
they play an important role in bacteria clearance. Thus some researchers also defined 
them as macrophages214,215. The ligand for CX3CR1 is CX3CL1/fractalkine, which is a 
transmembrane chemokine expressed at the surface of IEC and endothelial cells in the 
intestine. A recently report from Dr. Littman’s group showed that these previous 
reported non-migratory CX3CR1+ DCs shuttled non-invasive Salmonella to MLNs in a 
CCR7-dependent manner after antibiotic treatment216. Different from this opinion, using 
a minimally disruptive in vivo imaging approach (live two-photon confocal microscopy), 
Dr. Miller’s group showed that goblet cells were the cells sampling antigens from the 
lumen and delivered them to underlying CD103+ cells in the steady state217. Thus, the 
images indicating CX3CR1+ DCs extend dendrites into the gut lumen, and sampling 
antigen might be due to artifacts produced by from tissue processing. The dissemination 
of bacteria in mucosa and related host cells assisting the dissemination process has not 
been clarified.  
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In the case of oral L.m. infection, it has not been determined which cells are shuttling 
L.m. from the intestine to the MLNs. This cell type should possess two characters: the 
ability to migrate from intestine to MLNs, and the ability to recognize L.m. and allow L.m. 
survival within the cell. CD8α+ DCs from spleen have been shown to be the predominant 
cells harboring L.m. early after L.m. i.v. infection25,198. CD103+ DCs are migratory DCs in 
lung, skin and intestinal mucosa183,186,211. Thus, CD8α+ DCs expressing CD103 become 
our target candidate for L.m. translocation from intestine to MLNs. The majority of the 
CD8α+ DCs in LP and MLNs are CD11b-CD103+, and the majority of the CD11b-CD103+ 
DCs are composed of CD8α+ DCs. In Batf3-/- mice, CD11b-CD103+ DCs are absent from 
LP, and thus these mice provide an excellent tool for studying the dissemination of196 
oral L.m. infection. 
 
DCs in MLNs 
DCs are continuously migrating from blood stream and intestine to MLNs to present 
periphery antigens, prime T cells and induce gut mucosal tolerance. In MLNs, DCs can 
be categorized according to CD11b and CD103 expression. Both CD11b positive and 
negative subsets express CD103, but CD11bnegative/low populations express higher level 
of CD103 in the steady state218,219. CD103- DCs and CD103+ DCs are from different 
origins. Based on BrdU pulse-chase experiments, CD103+ DCs in MLNs are mostly 
migratory DCs from intestine tissues and present orally derived antigen to T cells and 
they are not derived from LP CD103- DCs, while CD103 negative DCs in MLNs are 
derived from blood precursor and present systemic antigen to T cells207.  Thus, CD103- 
DCs and CD103+ DCs might play different roles in pathogen dissemination according 
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the infection routes. About 40% of total MLN DCs are migratory DCs. In CCR7-/- mice, 
DCs migration from afferent lymph is greatly impeded205, and CD103+ DCs significantly 
reduced in MLNs, indicating that CD103+ DCs are migratory DCs from intestine219. 
However it is still not clear whether all the CD103+ DCs are migratory or whether all the 
resident DCs in MLNs are CD103- in steady state. 
 
Whether migratory DCs originate from LP or PPs is not clarified. Most of the DCs in LP 
are CD11b+ DCs, while most of DCs in PP are CD11b- DCs, and DCs collected from 
pseudo-afferent lymph are CD11b+ DCs220. The phenotype of the collected migratory 
DCs from pseudo-afferent lymph is similar as DCs in LP. Thus, it is possible that DCs in 
MLNs are mainly from LP. However, it is also possible that the phenotype of DCs 
changes during/after migration to MLNs or that only a small fraction of the DCs in PPs 
migrate to MLNs. After TLR7/8 stimulation, most DCs migrate out from LP to MLNs, 
while the DCs in the interfollicular area of PPs are not affected221. Additionally, DCs in 
other lymph nodes and secondary lymphoid tissues never migrate out186, so it is 
possible that DCs in PPs do not exit. However, for intestinal bacterial infection, bacteria 
are observed in both PPs and MLNs191,202,216,222 with fewer observed in the LP203. These 
evidences indicate that DCs in PPs may deliver live pathogens to MLNs, but it is 
possible that bacteria in LP are hard to observe due to the large area of intestinal 
surface. Nevertheless, the data from the tagged-L.m. oral infection in the guinea pig 
model support that migratory DCs are from PPs instead of LP as L.m. never penetrated 
into the LP in their model203.  
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D. The role of neutrophils in L.m. clearance 
Neutrophils are important leukocytes migrating into infection sites to presumably clear 
infections. They are defined by high level of CD11b and Ly6G expression223,224. It has 
been showed that patrolling neutrophils initially phagocytose some L.m. bacteria in the 
blood stream22. Only until recently, researchers identified a neutrophil-specific anti-Ly6G 
monoclonal antibody (mAb) for neutrophil depletion. Neutrophil studies before this mAb 
were performed using anti-Gr-1 mAb, which depletes both monocytes (Ly6Chigh) and 
neutrophils (Ly6G+)223. Using the neutrophil-specific depletion antibody, Carr, et al. have 
shown that neutrophil depletion only affects L.m. clearance in the liver but not in the 
spleen, unless a lethal infection dose is given41,42,223. Inflammatory monocytes 
(CD11b+Ly6chighCCR2+Ly6G-) are the critical cells managing L.m. clearance as shown 
in CCR2-/- mice and when the anti-Gr-1 mAb depletion is compared with neutrophil 
specific depletion using anti-Ly6G mAb41.   
 
XI. T cell responses in gut mucosa following L.m. oral infection 
Studies of T cell responses against L.m. infection are extensively accomplished in the 
i.v. infection model. As Listeria is a food-borne bacterium, antigen specific T cell 
responses in gut mucosa require additional studies. Compared with i.v. infection, oral 
infection induces enhanced antigen-specific CD8 T cell responses in LP, IEL and liver, 
and thus larger CD8 T cell memory population in LP and liver225-­‐227. Meanwhile, oral 
infection in CD40-/- or MHCII-/- mice leads to significantly impaired CD8 T cell responses 
in mucosa, while the CD8 T cell responses in liver and spleen is only partially 
reduced225, indicating that CD8 T cell responses in mucosa are more dependent on 
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CD4 T cell help. After priming, effector cells need to migrate to the infected tissues to 
effect clearance of the pathogen or infected cells. For gut-homing, α4β7 and CCR9 are 
critical for homing of activated T cells to the LP and IEL compartment219,228-230. 
MAdCAM-1 is the ligand of α4β7 and it is constitutively expressed on endothelial cells of 
lamina propria, PPs and HEV of MLNs 231-233. CCR9 is the receptor for CCL25, which is 
expressed by small intestine IEC234,235. α4β7 and CCR9 expression on T cells is 
induced and imprinted by CD103+ DCs mediated by retinoic acid produced by these 
DCs212,219,236,237. Although CD8 T cells can also be detected in intestinal mucosa 
following i.v. infection, oral infection leads to larger CD8 T cell population in intestinal 
mucosa225. This phenomenon can be explained by the intermediate expression of gut-
homing α4β7 on splenic CD8 T cells238. Expression of α4β7 and CCR9 is transiently 
upregulated after infection236, which results in limited migration of T cells into the 
mucosa.  
 
Following the cessation of migration into the mucosa, resident mucosal memory cells 
eventually develop238. Nearly all memory CD8 T cells in the epithelium upregulates 
CD69 and CD103 expression, while LP memory CD8 T cells express CD69 but only a 
subset of them express CD103239-241. As CD103 binds E-cadherin expressed by IELs, it 
is proposed to anchor memory T cells in the epithelium242. Expression of CD103 on 
CD8 effector cells is mediated by TGFβ, and the CD8 effector cells deficient of CD103 
are less retained in IEL compared to their CD103+ counterparts242,243. Although the 
migration of activated CD8 T cell to IEL is mediated by α4β7, the long-term retention of 
memory CD8 T cells in IEL is α4β7 independent but CD103 dependent228,243.  Different 
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from memory T cells from other non-lymphoid tissues, the memory T cells in IELs are 
tissue-resident memory T cells that do not recirculate to other tissues238,244. 
 
X. Summary 
L.m. are detrimental to immune compromised individuals and pregnant women9. 
However, recombinant L.m. are excellent vaccine vehicles for the vaccine therapies of 
cancer and other detrimental infections, and L.m. infection serves as a beneficial 
infection model to study host immunity12,13. Thus, due to both the risks and the benefits 
of this pathogen, additional studies on innate and adaptive immune responses to L.m. 
infection are required. L.m. elicits robust CD8 T cell responses and CD8 T cell 
responses are essential for the complete clearance of L.m., as well as long-term 
protection for secondary infection245. The activation, differentiation and memory 
formation of L.m.-specific CD8 T cells are dependent on CD4 T cell helps, a 
combination of costimulatory molecules, and affected by the inflammatory milieu246. 
Among the costimulatory molecules that are important for L.m.-specific CD8 T cell 
responses, PD-L1 is a comparatively less studied molecule. Most of the studies on PD-
L1 have focused on its inhibitory roles during chronic infections and in tolerance 
models161, although there are a few studies indicating that PD-L1 facilitates T cell 
activation171,172,175, and L.m. infection is one of the cases175. However, it is not known 
which factors determine the activation effect of PD-L1 and whether the known 
counterreceptors (PD-1 and CD80) are responsible for the positive activation effect on T 
cell responses, or the costimulatory effect of PD-L1 is through a novel pathway. Also, as 
L.m.-specific CD8 T cell responses are dependent on CD4 T cell helps, what are the 
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relations between PD-L1 costimulation and CD4 T cell helps are still unknown. Whether 
the activation effect of PD-L1 has to be dependent on CD4 T cell help or PD-L1 can 
directly affect CD8 T cells are to be studied. After activation, CD8 T effector cells 
differentiate to different precursors, but the impact of PD-L1 on the differentiation of 
short-lived effector cells and memory precursors have not been clarified. Moreover, the 
differentiation of CD8 T cells are sensitive to inflammatory environments, but the 
activation effect of PD-L1 on CD8 T cells have not been compared in different infection 
models. Thus, according to the characters of CD8 T cell responses to L.m. infection, we 
further analyzed PD-L1 costimulation on CD8 T cell responses to L.m. infection. 
 
Immunology studies have benefited significantly from the analysis of the i.v./i.p. L.m. 
infection model. However, the natural infection route for L.m. is through ingestion. What 
are known from the i.v./i.p. infection model could provide references to the study of L.m. 
dissemination and related immune responses in intestinal mucosa.  However, the 
phenotype and function of DCs varies sensitively in responses to tissue environments. 
Compared to splenic DCs, DCs in intestinal mucosa possess unique features of 
migration, antigen/pathogen acquisition and translocation, gut homing imprinting, and 
TGFβ production216-219,243. As a result, CD8 effector T cells and memory T cell in 
intestinal mucosa have distinct characters240. But the L.m. dissemination and 
subsequent innate immune responses in intestinal mucosa have not been clarified and 
need to be further studied in detail following oral infection. Salmonella cross intestinal 
barrier primarily via M cell acquisition, and initially replicated in PPs247. Antigen 
presentation occurrs locally in PPs after M cell endocytosis191. Different from Salmonella, 
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L.m. traverse the intestinal barrier via M cell acquisition into PPs or via intestinal 
epithelial cell invasion. Human but not L.m. E-cadherin expressed on IEC efficiently 
binds to wild type L.m.254,255. Thus, a murinized L.m. with internalin A mutation was 
generated to bind to mouse E-cadherin with similar affinity as the human counterparts. 
A recently report indicated that the murinized L.m. disseminate to MLNs more efficiently 
than the wild type L.m. following oral feeding infection, but the L.m. dissemination in the 
context of immune responses has not been analyzed. L.m. replicate intracellularly and 
spread from cell to cell to avoid host defense. But whether L.m. disseminate to MLNs 
extracellularly or shuttled intracellularly by host cells has not been studied. In i.v. 
infection model, CD8α+ DCs are responsible for shuttling L.m. from marginal zone to 
PALS, and CD103 marks intestinal migratory DCs, thus CD103+CD8α+ DCs are 
candidate cells shuttling L.m. from intestine to draining lymph nodes. Meanwhile, 
following oral Salmonella infection, Salmonella dissemination from intestinal mucosa to 
MLNs has been reported via DCs or macrophages transportation248,249. Thus, we 
analyzed the role of CD103+CD8α+ DCs in L.m. dissemination from intestine to MLNs, 
antigen presentation site and duration in compared with i.v. L.m. infection as well as oral 
Salmonella infection, and we characterized the organization of immune responses to 
L.m. dissemination in the draining lymph nodes following oral infection. 
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XIV. Figures 
A. Figure 1. The structure of the spleen. 
T cell zones (PALS, blue, anti-CD8); follicular B cells (B, green, anti-B220); CD169+ 
macrophages (MZ, red, anti-CD169/MOMA); bridging channels (BC); central arteriole 
(CA, yellow, anti-CD31)  
 
B. Figure 2. Structure of lymph node 
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C. Figure 3. Gut mucosa 
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CHAPTER 2 
 
MATERIAL AND METHODS 
Mice  
Batf3-/- mice (C.129S-Batf3tm1Kmm/J) breeders and Balbc/j mice and were purchased 
from The Jackson Laboratory (Bar Harbor, ME).  C57BL6/N used for i.v. L.m. infection 
and OTI transfer assays were purchased from Charles River-National Cancer Institute. 
OTI mice on RAG-/- background and Batf3-/- mice were bred in University of Connecticut 
Health Center. All mice were housed in accordance with the Animal Care Committee at 
the University of Connecticut Health Center. 
 
PP-deficient mice 
Pregnant C57BL6 mice were treated with IL-7Ra mAb on day 14.5 of embryonic 
development to inhibit the development of PP in embryo189,250. Corresponding isotype 
control was applied to the control group. 
 
Immunization and Infection 
L.m. or Salmonella enterica serovar typhimurium SL1344 were sub-cultured from 
overnight cultures and harvested in log-phase. For i.v. L.m. infection, mice were infected 
with 1x103 cfu L.m.-OVA(10403s) or 1x105 pfu of VSV-OVA i.v.. For oral infection, L.m.-
lnlAm(10403s) or L.m.-lnlAm-OVA(10403s) were a generous gift from Dr. Nancy Freitag 
(U of Illinois Chicago). Mice were individually housed, and food and water was deprived 
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for 4 hours before being fed with 2x109 cfu (primary) lnlAm-L.m. (10403s) or lnlAm-L.m.-
OVA(10403s), or with 5x107 cfu Salmonella enterica serovar typhimurium SL1344 
loaded on an ~1 cm3 piece of white bread. For irradiated L.m. (IRL), Balb/cJ or Batf3-/- 
mice were gavaged with 4x109 cfu IRL, which was generated as previously described41.  
 
mAb treatment  
Mice were treated with 200µg mAb specific for PD-L1 (10F.9G2251), PD-L2 (TY25252), 
PD-1 (RMP1-14253) or 43H12 (PD-L1-CD80170), i.p. on day -1 and every other day after 
infection. CD4 T cell depletion was done by treating mice with 200µg GK1.5 i.p. 3 days 
before infection and every other day after infection. 
 
BrdU incorporation assay 
Mice were treated with 1mg BrdU i.p. 16hrs before sacrificing. Staining of BrdU 
incorporation followed the BrdU Flow kit protocol (Becton-Dickinson). 
 
Flow cytometry 
Single-cell suspensions were prepared by collagenase digestion as previously 
described254. Lymphocytes (5 × 106 cells/ml) were stained with peptide:MHC tetramers, 
and other antibodies as indicated. The LLO-I-Ab tetramer67 was generously provided by 
Dr. Marc Jenkins (UMINN). 
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Calculation of bacterial burden in tissues 
For i.v. infection, C57BL6 mice were infected with 1x105 cfu L.m.-OVA(10403s). Spleen 
and liver were harvested on day 5 after i.v. infection to calculate bacterial burden. 
Spleen, MLNs, and liver were homogenized in RPMI1640 medium without antibiotics 
and incubated in PBS containing 1% saponin for 1 hour. Small intestine was gently 
flushed with RPMI1640 medium without antibiotics to remove lumenal contents, 
homogenized in 1% saponin with a gentleMACS dissociator for 40sec twice, and 
incubated in PBS containing 1% saponin for 1 hour. Serial dilutions of the homogenate 
were plated on Bacto brain–heart infusion agar containing 50 µg/ml streptomycin. 
Colonies were enumerated after 36hrs at 37°C. For bacterial burdens with gentamicin 
treatment, 1mg gentamicin (Gibco) was injected s.c. into Balb/cJ mice 4hr after oral 
infection. Three days later bacterial burdens in the MLNs and liver were measured. For 
Salmonella infection, bacterial burden was analyzed four days after infection by plating 
tissue lysates on BHI agar without antibiotics and counting colonies 24hrs later.  
 
Cell transfers and CFSE labeling 
1x106 CFSE labeled CD45.1 OTI Rag1-/- cells were transferred into CD45.2 C57BL/6 
hosts which were orally infected with lnlAm-L.m.-OVA one day previously. Lymphoid 
tissues were harvested 16hrs later and cultured in complete RPMI 1640 in the presence 
of 10IU human IL-2 for three days at 37°C with 5% CO2 before cells were harvested and 
CFSE dilution was analyzed. To analyze the duration of antigen presentation, CFSE 
labeled CD45.1 or CD45.1+CD45.2+ OTI Rag1-/-  OTI cells were transferred into CD45.2 
C57BL/6 hosts on day 3, 6 10, and 14 after oral lnlAm-L.m.-OVA infection. Lymphoid 
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tissues were harvested 3 days after transfer, and CFSE fluorescence was analyzed by 
flow cytometry. 
 
Preparation of single cell suspensions and flow cytometry 
Spleens, MLNs and PPs were treated with collagenase and homogenized by 
mechanical disruption of the tissues filtered through 70µm mesh. Following erythrocyte 
lysis using Tris-ammonium chloride, cells were washed and resuspended in RPMI1640 
containing 5% bovine serum. Isolation of intraepithelial lymphocytes (IEL) and lamina 
propria lymphocytes was performed as previously described52. For staining, 5X106 
cells/ml cells were resuspended in FACS buffer (0.2% BSA, 0.01% NaN3 in PBS) and 
stained with indicated Abs at 4°C for 30min. Abs were purchased from BD Pharmingen, 
eBioscience or BioLegend. Peptide:MHC tetramers staining was applied at room 
temperature for 1hr. Following staining, cells were washed in FACS Buffer and fixed 
with 2% paraformaldehyde in PBS. Flow cytometry was performed with a LSR II (BD 
Biosciences), and data were analyzed using FlowJo software (Tree Star, Ashland, OR).  
 
Immunohistochemistry 
MLN and PP were harvested, cryopreserved with O.C.T compound and sectioned with 
a Leica CM1850 cryostat. 20-µm-thick sections were acetone-fixed, and stained for 60 
min at room temperature with a combination of primary Abs in PBS with 2% goat serum 
and FCS: Alexa Fluor 647 anti-mouse Gr-1 (RB6-8C5), Pacific Blue anti-mouse CD103 
(2E7), Alexa Fluor 488 anti-mouse CD103 (2E7), FITC anti-mouse CD3e (145-2C11), 
Pacific Blue anti-mouse CD11b (M1/70), Alexa Fluor 647 anti-mouse Ly6G (1A8) were 
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from BioLegend; Pacific Orange anti-mouse CD45R (B220) was from Invitrogen; APC 
hamster anti-mouse CD11c (HL3) was from BD; biotinylated anti-mouse macrophages 
(MOMA-1) was from BMA Biomedicals (Augst, Switzerland) and L.m. was stained with 
BD Difco™ Listeria O Antiserum Poly Types 1 & 4 as primary Ab. Sections were 
washed with 1xPBS and incubated with secondary Abs diluted in 2% normal goat serum 
and 1xPBS for 60 min at room temperature: For L.m. staining, Alexa Fluor 546 or 647 
F(ab’)2 fragment of goat anti-rabbit IgG(H+L) from Invitrogen was applied; For CD169+ 
macrophage staining, Cy3 streptavidin or Alexa Fluor 647 streptavidin from Invitrogen 
was used. Following staining, sections were washed and mounted. Imaging was 
performed using a Zeiss LSM780 or LSM510 Meta confocal microscope with 10x0.5 
water and 40x1.2 water lenses, and images were processed with Imaris software 
(BITPLANE Scientific Software). L.m. stainings were highlighted by spheres using 
Imaris when multiple colors were applied to allow better visualization. 
 
Statistical analysis 
Statistical significance was determined with unpaired student’s t-test or a one-way 
ANOVA test (for data containing more than 2 groups). Statistical significance of 
bacterial burden was determined with Mann-Whitney test or Kruskal-Wallis test (for data 
containing more than 2 groups). Tests were applied by GraphPad Prism software. 
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CHAPTER 3 
 
A POTENTIAL NEW PATHWAY FOR PD-L1 
COSTIMULATION OF THE CD8 T CELL RESPONSE 
TO LISTERIA MONOCYTOGENES INFECTION 
 
I. Summary 
PD-L1 is an important negative regulator of T cell immune responses via interactions 
with PD-1 and CD80. However, PD-L1 can also act as a positive costimulator, but the 
relevant counterreceptor is not known. We analyzed the role of PD-L1 in CD8 T cell 
responses to infection with L.m. or VSV. PD-L1 blockade impaired antigen-specific CD8 
effector T cell expansion in response to L.m., but not to VSV infection, particularly 
limiting short-lived effector cell differentiation. Simultaneous CD4 T cell depletion and 
anti-PD-L1 blockade revealed that PD-L1 provided costimulation even in the absence of 
CD4 T cells. Most importantly, specific blockade of PD-L1 binding to CD80 or to PD-1 
did not recapitulate PD-L1 blockade. The results suggested that PD-L1 plays an 
important costimulatory role for antigen-specific CD8 T cells during L.m. infection 
perhaps through a distinct receptor or interaction epitope. 
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II. Introduction 
Activation of antigen specific CD8 T cell requires the interaction between TCR 
expressed on T cells and cognate peptide-MHCI complex on antigen presenting cells107. 
Only TCR recognition without costimulation signal leads to T cell anergy.  During anergy 
stage, T cells are functionally inactive but a live for certain period before apoptotic110. 
Optimal T cell activation requires three signals: 1) interaction between TCR and the 
cognate peptide-MHC complex, 2) positive costimulation of antigen-specific T cells to 
promote expansion and survival111; and 3) cytokines that facilitate T cell differentiation, 
expansion, and survival112. Besides positive costimulation, there are coinhibitory signals 
crucial for maintaining immune system homeostasis and limiting deleterious 
inflammatory responses as well as autoimmunity109. The B7:CD28 costimulatory family 
consists of both positive and negative costimulatory molecules including CD28, CTLA4 
and their ligands CD80 (B7-1) and CD86 (B7-2), and PD-1 and its ligands PD-L1 and 
PD-L2. PD-1 binds to both PD-L1 and PDL-2 and is upregulated after T cell activation, 
which serves to minimize inflammatory side effects159. PD-1 also contributes to T cell 
exhaustion during chronic infection and in tolerance model163,164. PD-1 preferentially up-
regulates on exhausted T cells induced by chronic infection strain of LCMV than acute 
infection strain or naïve T cells. Blocking PD-1 or PD-L1 can result in reversal of T cell 
exhaustion and viral clearance164,255. In a T cell tolerance model, blocking PD-L1 
augmented T cell expansion and function as compared to PD-1 blockade167,170. The 
difference between PD-1 and PD-L1 blocking effect implied the possible existence of a 
second receptor for PD-L1, which was subsequently identified as CD80164,167. In 
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addition, it was recently demonstrated that the PD-L1:CD80 interaction promotes 
peripheral tolerance170.  
 
In contrast to the inhibitory roles played by the PD-1 pathway, PD-L1 can also serve as 
a positive costimulator. PD-L1 promotes bacterial clearance174, Th1 differentiation and 
expansion171 and the development of colitis172. In the current study, we investigated the 
role of PD-L1 in the regulation of the endogenous antigen-specific CD8 T and CD4 T cell 
responses to bacteria and virus infections. We unveiled a costimulatory role for PD-L1 
in the CD8 T cell response to L.m., but not to VSV infection. PD-L1 signaling augmented 
the proliferation of responding CD8 T cells and modulated differentiation of the short-
lived effector cell subset via a CD4 T cell independent mechanism. Moreover, PD-L1 
signals were delivered through a PD-1 and CD80 independent pathway, thereby 
suggesting the existence of an additional PD-L1 ligand.   
 
III. Result 
Upregulation of PD-L1 on CD8 T cells after primary L.m. or VSV infection 
We examined PD-L1 expression after i.v. infection with L.m.-OVA or VSV-OVA. Two 
days after infection of L.m. or VSV, PD-L1 was markedly upregulated on bulk CD4 T 
cells, CD8 T cells, and B cells (Figure 1A). PD-L1 expression on CD8 T cells peaked 
around day 2 post infection and subsequently declined (Figure 1B). L.m. infection 
induced higher levels of PD-L1 on bulk CD8 T cells as compared to levels induced by 
VSV infection (Figure 1B). Moreover, CD11ahigh effector/memory phenotype CD8 T cells 
expressed substantially more PD-L1 as compared to their CD11alow naïve counterparts 
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(Figure 1C). Thus, PD-L1 expression was transiently upregulated on T cells after L.m. 
or VSV infection, similar to the expression profile of other costimulatory molecules after 
activation256,257. 
 
PD-L1 blockade inhibits the CD8 T cell response to L.m. infection  
To test the potential role of the PD-L1 axis in antigen-specific CD8 T cell response, we 
treated mice with anti-PD-L1 (10F.9G2251), anti-PD-L2 (TY25252), or anti-PD-1 (RMP1-
14253) blocking mAb throughout the infection. The pMHCI tetramer-OVA257-264/Kb was 
used to identify antigen-specific CD8 T cells in spleen on day 8 post L.m.-OVA or day 7 
post VSV-OVA infections, near the peak of the responses. The VSV-specific CD8 T cell 
response was not affected by anti-PD-L1, anti-PD-L2, or anti-PD-1 mAbs (Figure 2A 
and data not shown). In contrast, blocking PD-L1 resulted in an ~80% inhibition of the 
anti-L.m. CD8 T cell response, while PD-L2 or PD-1 blockade had no effect (Figure 2B). 
During L.m. infection, CD4 T cells provide help to CD8 T cells59,74. PD-1:PD-L1 
suppressive signal was shown on CD8 T cells in the absence of CD4 T cell help164. 
However, the LLO190-201/I-Ab-specific CD4 T cell response was not affected by PD-L1 
blockade (Figure 2C), indicating that a loss of CD4 T cell help could not explain the 
inhibition of the CD8 T cell response. We also examined the production of cytokines 
after PD-L1 blockade. While the overall number of cytokine producing cells decreased 
after PD-L1 blockade, as expected based on the loss of tetramer+ cells, the cells that 
produced IFNγ, TNF, or IL-2 did so at levels comparable to their normal counterparts 
(Figure 3B-C). However, the percentage of polyfunctional antigen-specific CD8 T cells, 
i.e. those that produced all three cytokines, was reduced by PD-L1 blockade (Figure 
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3A). Thus, PD-L1 controlled both the magnitude and the functionality of the CD8 T cell 
response to L.m. infection.  
 
Effector T cell heterogeneity is a hallmark of CD8 T cell responses to infections53. Based 
on KLRG1 and IL-7R expression levels, four populations of effector cells can be 
identified: early effector cells (KLRG1- IL-7R-; EEC) that give rise to the other subsets, 
short-lived effector cells (KLRG1+ IL-7R-; SLEC) that do not survive long-term, memory 
precursor effector cells (KLRG1- IL-7R+; MPEC) that survive to form the memory pool, 
and double positive effector cells (KLRG1+ IL-7R+; DPEC) whose origin is unclear258. A 
number of factors have been identified that affect the lineage decision toward MPEC vs. 
SLEC development53,55. We therefore examined whether PD-L1 played a role in effector 
subset development in response to L.m. infection. Blockade of PD-L1 resulted in a 
decrease in all effector subsets with the greatest effect on SLEC generation (Figure 4). 
Blockade of PD-L1 during L.m. infection impaired bacterial clearance, while PD-1 
blockade enhanced bacterial clearance (Figure 5). This finding further indicated distinct 
functions for PD-L1 and PD-1 during the anti-L.m. response.  
 
To further understand the mechanism of PD-L1 costimulation, we examined early 
proliferation of antigen-specific CD8 T cells. To this end, we administered BrdU 16hrs 
before sacrifice to infected mice treated with or without PD-L1 blockade. Incorporation 
of BrdU into CD8 T cells was analyzed on day 5 post-infection (Fig. 6A-C).  While most 
tetramer+ cells from the control mice incorporated BrdU, fewer tetramer+ cells 
incorporated BrdU in PD-L1 blockade group (Figure 6A). Furthermore, in those Ova/Kb-
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specific CD8 T cells that did incorporate BrdU during PD-L1 blockade the quantity of 
incorporation was reduced (Figure 6B). Using annexin V staining, no difference in 
apoptosis was observed between the groups (Figure 6C). Thus, PD-L1 costimulation 
operated by enhancing the proliferation of antigen-specific CD8 T cells.  
 
PD-L1 costimulates CD8 T cells independent of CD4 T cell help  
PD-L1 preferentially costimulated the CD8 T cell response with little effect on the CD4 T 
cell response (Figure 2C). Since the CD8 T cell response to L.m. is CD4 T cell 
dependent74, we next tested whether PD-L1 operated independently or cooperatively 
with CD4 T cells to augment the CD8 T cell response. To test this, we blocked PD-L1 
separately or in conjunction with CD4 T cell depletion. While both treatments inhibited 
the response, anti-PD-L1 blockade was somewhat more effective than CD4 depletion 
(Figure 7A-B). However, CD4 T cell depletion together with anti-PD-L1 blockade 
substantially enhanced the inhibitory effect of either treatment alone. We further 
calculated the ratio of antigen-specific CD8 T cell numbers with or without PD-L1 
blockade and CD4 T cell depletion. The level of inhibition was similar in the presence or 
absence of CD4 T cells (Figure 7B). We noticed that the CD11a expression on 
tetramer-negative CD8 T cells appeared to increase after PD-L1 blockade or CD4 
depletion (Figure 7A). However, the total number of splenic CD11ahigh CD8 T cells was 
not different between the groups (Figure 7C), suggesting that CD11a upregulation might 
be non-specific and the result of alterations in the inflammatory environment. Overall, 
these data indicated that both PD-L1 costimulation and CD4 T cell help were required 
for optimal CD8 T cell responses to L.m. infection. 
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PD-L1 costimulation occurs independent of binding to PD-1 and CD80  
The two known counterreceptors of PD-L1 are PD-1 and CD80, both of which are well 
documented to transduce negative regulatory signals during T cell activation159,170. To 
scrutinize through which ligand PD-L1 mediated costimulation, we took advantage of 
mAbs that specifically block PD-L1 binding to PD-1 (RMP1-14) or to CD80 (43H12170) 
and compared their ability to block the CD8 T cell response during L.m. infection with 
the general inhibition of PD-L1 by 10F.9G2. Surprisingly, treatment with either RMP1-14 
or 43H12 failed to inhibit the response unlike 10F.9G2 treatment (Figure 8A-B). As an 
important positive control, we confirmed the blocking efficiency of 43H12 in a previously 
described T cell tolerance model170. Treatment with 43H12 greatly enhanced the CD8 T 
cell response in this model (data not shown). The consistent increase in the CD4 T cell 
response (data not shown) and better L.m. clearance (Figure 5) with RMP1-14 
treatment, indicating that the mAb was also operating. To insure that the lack of 
inhibition of the CD8 T cell response by PD-L1-CD80 blockade (43H12) or PD-1 
blockade (RMP1-14) was not due to compensation through CD80 or PD-1, we blocked 
both interactions simultaneously, and found no inhibition (Figure 8B). This result was 
also confirmed by blocking CD80 with 1G10 (Figure 8B), which has been shown to 
block CD80:PD-L1 interaction in vitro167. In this experiment, anti-PD-1 treatment 
resulted in an increase in antigen-specific CD8 T cells (Figure 8B), but this was not a 
consistent finding. Further, to exclude the possibility that the reduced antigen-specific 
CD8 T cell response was caused by a potentiated inhibitory effect via enhancing PD-
L1:PD-1 interaction due to 10F.9G2 mAb treatment, we blocked PD-1 in conjunction 
with 10F.9G2 treatment which again demonstrated that 10F.9G2 blockade of PD-L1 
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reduced the antigen-specific CD8 T cell response (Figure 8B). Taken together, these 
data suggested that PD-L1 costimulation was mediated either by binding to an epitope 
on CD80 or PD-1 that was not blocked by the available mAbs or by interaction with a 
third unknown binding partner. 
 
IV. Conclusion and Discussion 
While much research has focused on the inhibitory effects of the PD-L1/PD-1 axis, 
positive costimulatory effects of these and other predominantly negative regulators have 
also been described. The underlying reasons that determine negative versus positive 
regulatory events are not clear. Our studies show obvious contextual cues that control 
the requirement for PD-L1 mediated costimulation since the CD8 T cell response to 
VSV infection was PD-L1 independent while the response to L.m. infection integrated 
positive signals from PD-L1 costimulation (Figure 2). Previous work also showed a role 
for PD-L1 costimulation in the CD8 T cell response to L.m. infection174,175 that is 
mediated through IFNγ259. Expression of counterligands that direct the choice between 
positive and negative regulation may be differentially controlled during distinct immune 
responses. While the identity of the putative third PD-L1 ligand is not yet known, the 
expression of this counterreceptor could be disparate between, for example, VSV and 
LM infection resulting in the different outcomes of the CD8 T cell response during PD-L1 
blockade that we observed. This ligand may be distinct from PD-L1 and CD80 or could 
represent an interaction between PD-L1 and epitopes on these molecules that remain 
accessible in the presence of the available blocking antibodies. This possibility is 
supported by the finding that PD-L1 blockade doesn’t impair PD-1-deficient CD8 T cells 
54 	  	  
expansion in the response to L.m. infection259. Nonetheless, the ultimate effect was 
enhancement of the response, indicating a distinction in the downstream signaling 
events mediated through PD-L1 interactions which drive negative regulatory events 
versus the positive effects described here. 
 
Our data also indicated that both positive and negative regulations were occurring 
simultaneously through PD-1 and PD-L1. Thus, while PD-L1 inhibition reduced the 
overall CD8 T cell response and decreased protection, PD-1 blockade enhanced 
bacterial clearance without consistently affecting the overall magnitude of the CD8 T cell 
response. The latter result suggested that PD-1 may be inhibiting the functional abilities 
of CD8 T cells or was affecting innate immune system components. Of additional 
significance was the demonstration that PD-L1 costimulation operated cooperatively, 
but independently of CD4 T cell help. Thus, the summation of the positive and negative 
signaling events mediated through PD-1/PD-L1 family members served to fine-tune the 
overall immune response to provide protection while maintaining the integrity of the 
host. 
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V. Figures 
Figure 1. PD-L1 induction in response to infection. A, PD-L1 expression on CD4 T, 
CD8 T, and B cells on day 2 after L.m. or VSV infection. Filled histogram: naive control. 
Open histogram: day 2 after L.m. or VSV i.v. infection. B, Comparison of PD-L1 
expression on total CD8 T cells 2 days after L.m. or VSV infection. C, Comparison of 
PD-L1 expression by naïve (CD11alow) and activated/memory (CD11ahigh) CD8 T cells 
and representative 2-D plot of CD11a versus PD-L1 expression. Data were analyzed by 
Student’s t test. (***p<0.001). Gating strategy for T cells is based on CD4, CD8 and 
CD3 expression. Data are representative of three independent experiments with five 
mice per group. 
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Figure 2. PD-L1 costimulates the CD8 T cell response to L.m. infection. 
A, OVA257–264/Kb+ splenic CD8 T cell population seven days after VSV-OVA infection 
from mice treated with IgG isotype control, anti-PD-1 (RMP1-14), or anti-PD-L1 
(10F.9G2). B, (Left panel) Compiled data showing the total numbers of OVA257–
264/Kb+ splenic CD8 T cells eight days after LM-OVA infection from mice treated with IgG 
isotype control, anti-PD-1(RMP1-14), anti-PD-L1(10F.9G2), or anti-PD-L2 (TY25). 
(Right panel) Representative dot-plot of the CD8 T cell response from control or anti-
PD-L1 treated mice eight days after infection. Data were analyzed by two-way ANOVA. 
(*p<0.05. ns, non significant). C, (Left panel) Compiled data showing the total numbers 
of LLO190–201/I–Ab+ CD4 T cells of the spleen from day 8 L.m. infected mice treated with 
anti-PD-L1 (10F.9G2) compared with IgG isotype control. (Right panel) Representative 
dot-plot of the splenic CD4 T cell response from control or anti-PD-L1 treated mice eight 
days after infection. Data were analyzed by Student's t test. Data are representative of 
three independent experiments with five mice per group. 
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Figure 3. PD-L1 enhances multifunctional effector CD8 T cell generation. Mice 
were infected i.v. with 1000 cfu L.m.-OVA and treated with anti-PD-L1 or control IgG. 
Eight days later splenocytes were stimulated in vitro with SIINFEKL peptide for 5 hours 
in the presence of brefeldin A. Production of IL-2, IFNγ and TNF was measured by 
intracellular staining and flow cytometry. A, The frequency of IFNγ+TNF+IL-2+antigen-
specific CD8+ T cells. B–D, Comparison of the mean fluorescent intensity (MFI) of 
staining for each cytokine. Values are means +/− standard error. Data are 
representative of three independent experiments with five mice per group. Data were 
analyzed by student t test. (*p<0.05, ns, not significant). 
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Figure 4. PD-L1 costimulation facilitates SLEC differentiation. Eight days after L.m.-
OVA infection, SLEC, MPEC, DPEC and EEC population was analyzed within OVA257–
264/Kb+ splenic CD8 T cell population according to their KLRG1 and IL-7R expression. A, 
Graphs show the compiled proportion of each subset with or without anti-PD-L1 
blockade (SLEC: KLRG1+ IL-7R-; MPEC: KLRG1−, IL−7R+; EEC: KLRG1−, IL−7R−; 
DPEC: KLRG1+, IL−7R+). B, representative plots of the OVA-specific CD8 T cell 
response and the expression of CD127 and KLRG1 by gated tetramer+ cells with or 
without PD-L1 blockade. Data are representative of three independent experiments with 
five mice per group. (*p<0.05, **p<0.01, ***p<0.001, ns, not significant). 
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Figure 5. PD-L1 costimulation augments protection against L.m. infection. Mice 
were infected with 1×105 cfu L.m.-OVA i.v. and treated with anti-PD-L1, anti-PD-1 or 
control IgG. The bacterial burden in spleen (A) and liver (B) was analyzed five days 
later. Data are representative of two independent experiments with ten mice per group. 
Data were analyzed by Mann-Whitney test. (*p<0.05, **p<0.01, ***p<0.001, ns, not 
significant). 
 
 
61 	  	  
 
 
Figure 6. PD-L1 augments Ag-specific CD8 T cell proliferation. A-B, Brdu 
incorporation of OVA tetramer+CD8+ T cells. Mice were administered BrdU 16 hrs 
before sacrificing on day 5 after i.v. L.m. infection with or without PD-L1 blockade. C, 
Annexin V staining of tetramer+ cells. Data were analyzed by Student’s t test, 
(**p<0.01). Data are representative of three independent experiments with five mice per 
group. 
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Figure 7. PD-L1 costimulation is independent of CD4 T cell help. A, Representative 
dot-plots of the antigen-specific CD8 T cell response eight days after L.m.-OVA infection 
following PD-L1 blocking with or without CD4 T cell depletion. B, The total numbers of 
OVA257–264/Kb-specific CD8 T cells or panel C, the total numbers of CD11ahigh CD8 T 
cells in the spleen from day 8 L.m. infected mice treated with IgG isotype control, anti-
PD-L1 (10F.9G2), anti-CD4 (GK1.5), or both anti-PD-L1 and anti-CD4. Comparison of 
the magnitude of blocking between PD-L1 blockade with or without CD4 T cell depletion 
is shown under the bar graph in panel B. Data are representative of three independent 
experiments with five mice per group. ***p<0.001. 
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Figure 8. PD-L1-mediated costimulation occurs independently of known CD80 or 
PD-1 interactions. A, Representative dot-plots and B, total cell numbers of the OVA257–
264/Kb-specific splenic CD8 T cell response eight days after L.m. infection from mice 
treated with IgG isotype control, anti-PD-L1 (10F.9G2), or with an mAb that blocks PD-
L1 interaction with CD80 (43H12), or with anti-PD-1 (RMP1-14). C, Total numbers of 
OVA257–264/Kb-specific splenic CD8 T cells eight days after L.m. infection from mice 
treated with IgG isotype control, anti-PD-1 (RMP1-14), anti-PD-L1 (10F.9G2), both anti-
PD-L1(10F.9G2) and PD1(RMP1-14), both anti PD-1(RMP1-14) and 43H12 or both 
anti-PD-1(RMP1-14) and anti-CD80 (1G10). Data are representative of three 
independent experiments with five mice per group. Data were analyzed by two-way 
ANOVA, (*p<0.05, **p<0.01, ***p<0.001, n.s., not significant). 
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VI. Summary Figure 
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CHAPER 4 
 
CELLULAR DYNAMICS OF THE EARLY MUCOSAL 
IMMUNE RESPONSE TO ORAL LISTERIA 
MONOCYTOGENES INFECTION 
 
I. Summary 
Listeria monocytogenes is a food borne, disease-causing bacterium. However, the rules 
governing Listeria dissemination and the subsequent innate and adaptive immune 
responses in the intestinal mucosa following oral infection have not been fully 
delineated. Thus, this study focused on the immune response to oral L.m. infection 
using a murinized L.m. to better mimic infection in humans. Initially, infection was limited 
to the gut mucosa, and antigen presentation rapidly occurred within mesenteric lymph 
nodes and Peyer’s patches. However, PPs were dispensable for bacterial dissemination. 
Intracellular L.m. was initially shuttled through the subcapsular sinus into the 
interfollicular zones of the MLNs and subsequently appeared in the T cell zone.  In 
response, an organized cellular architecture rapidly developed in which Ly6G+ 
neutrophils initially surrounded L.m., followed by formation of an outer zone of CD103+ 
DCs and T cells, indicating a potential antigen presentation site. However, depletion of 
neutrophils had no effect on mucosal clearance of L.m. while depletion of monocytes 
resulted in enhanced bacterial replication and altered localization of CD169+ 
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subscapsular macrophages. Interestingly, dissemination of L.m., but not Salmonella, to 
the MLNs required Batf3-dependent DCs. Moreover, Batf3-dependent DCs were also 
required for trafficking of irradiated Listeria to the MLNs, suggesting the existence of a 
receptor-mediated pathway for L.m. acquisition, rather than provision of a replicative 
niche.  In sum, our data characterized the organization of innate immune responses to 
an orchestrated Listeria dissemination pattern in the gut mucosa.  
 
II. Introduction 
The intestinal mucosa is constantly exposed to a large collection of microbes that is 
essential for maintaining homeostasis of the mucosal immune system2,3. Inflammatory 
diseases like inflammatory bowel disease (IBD), and even rheumatoid arthritis can be 
associated with gastrointestinal infection1,5. L.m. is a saprophytic bacterium that is 
usually transmitted to humans through contaminated food9.  L.m. can cause severe 
disease including meningitis and spontaneous abortion and is particularly deleterious in 
immune-compromised individuals and the aged6,7, with a mortality rate of approximately 
20%8.  Nevertheless, recombinant L.m. are being developed as potential vaccine 
vectors for cancer and other infections11-13,260. L.m. has also been extensively employed 
as a tool to study T cell immunity, since T cells are required for protective immunity 
against L.m infection8,261. Although the natural infection route for L.m. is through 
ingestion, most studies examining host immune responses against L.m. have been 
performed using i.v. or i.p. infection models, with some notable exceptions225,227.  
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In the intestinal mucosa, L.m. traverses the intestinal barrier via M cell uptake into PPs 
or via intestinal epithelial cell invasion mediated by interaction between internalin A 
expressed on the surface of L.m. and E-cadherin expressed on host IEC262,263. 
However, human but not mouse E-cadherin binds to internalin A with high affinity264. To 
optimize L.m. infection in mouse models, murinized L.m. were designed that express a 
mutant version of internalin A that allows binding to mouse E-cadherin with similar 
affinity as its human counterpart201,261. A recent report shows that the lnlAm-L.m. 
disseminates more efficiently than wild type L.m. to MLNs in a murine model following 
oral infection202, but the immune response was not analyzed.  
 
The process by which L.m. is disseminated after i.v. infection has been examined in 
some detail and presents some unusual aspects. Blood-borne L.m. is shuttled by the 
cooperation of platelets and the complement component C3 to the marginal zone of 
spleen23,26. There, CD8α+ DCs acquire the platelet-associated L.m. by an unknown 
process, and shuttle the bacteria to the periarteriolar lymphoid sheaths of the spleen26. 
Thus, Batf3-deficient mice which lack CD8α+ DCs are resistant to i.v. L.m. infection, 
since bacterial replication in the spleen is severely blunted198.  The PALS are the major 
antigen-presentation sites after i.v. L.m. infection26 and the site of initial CD8 T cell 
expansion in response to infection265. Whether CD8α+ DCs are carriers, which 
preferentially recognize L.m. or provide a growth niche for L.m. is unknown, and L.m. 
dissemination and antigen-presentation after oral infection has not been analyzed in 
detail. In this study, we focused on the mechanism of dissemination of InlAm-L.m. and 
the corresponding immune response following oral infection. Our results identified an 
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orchestrated pattern of L.m. dissemination and localization in the lymphoid tissues of 
the intestinal mucosa, which was characterized by a rapid innate immune response and 
reorganization of cellular components of the MLN. Moreover, our findings demonstrated 
that L.m., but not Salmonella, shuttling to MLN was Batf3-dependent, and likely 
mediated via receptor-mediated bacterial acquisition.  
 
II. Results: 
L.m. rapidly appears in the MLN after intracellular dissemination from the 
intestine. 
We analyzed lnlAm-L.m. dissemination and propagation in different tissues after oral 
infection. To better mimic a natural infection, mice were fed with L.m. impregnated 
bread and bacterial burdens in various tissues were then analyzed at different time 
points after infection (Figure 9). At 24hrs after infection bacteria were present in the 
intestine and MLNs but were not found in the spleen or liver. However, by 48hrs after 
infection, L.m. were located in the intestine, MLNs, liver and spleen. The bacterial 
burden peaked at ~ days 2-3 in all tissues and followed by bacterial clearance which 
was largely complete by day 8 after infection.  To determine the extent to which L.m. is 
carried intracellularly from the intestine to the MLNs, mice were treated with gentamicin, 
which kills extracellular L.m. while sparing intracellular L.m.26. The L.m. burden in the 
MLNs was unaffected while bacterial burden in the liver was decreased ~10-fold after 
antibiotic treatment compared to tissues from untreated animals (Figure 10A-B). Thus, 
L.m. was shuttled to the MLN intracellularly, while dissemination to the liver involved 
extracellular transport or replication. The reduced bacterial burden in the liver after 
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gentamicin treatment also served as a positive control for antibiotic treatment. As L.m. 
infection was limited to gut tissues at 24hrs after oral infection, we next analyzed the 
location and duration of antigen presentation by evaluating the proliferation of CFSE-
labeled OTI cells in different tissues after infection with lnlAm-L.m. producing ovalbumin 
using an assay that circumvents any issues of T cell migration266. OTI cells proliferated 
in MLNs and PPs but not in the spleen 24hrs following oral infection (Figure 11A). We 
also tested the duration of antigen presentation by transferring CFSE-labeled OTI cells 
at different times after infection (Figure 11B).  OTI cells transferred at 3 days after 
infection underwent robust proliferation in all tissues tested. By day 6 after infection the 
induction of proliferation declined in all sites and by day 10 only a low level of 
proliferation was detectable and proliferation was undetectable by day 14 after infection. 
Thus, antigen was initially available only in mucosal tissues and was present for ~10 
days after oral infection.  
 
Peyer’s patches are dispensable for L.m. dissemination from the intestine  
Since the M-cells overlying PPs act to transport luminal antigens into PPs to elicit 
immune responses against intestinal pathogens267,268, we next analyzed the role of PPs 
in bacteria dissemination. To confirm that L.m. appeared in PPs after oral infection, we 
performed confocal microscopy. L.m. accumulated in PPs at 24hrs following oral 
infection (Figure 12A). To then test the role of PPs in further L.m. dissemination, we 
generated PP-deficient mice by treating pregnant mice with anti-IL-7R mAb on day 14.5 
of gestation189,250189,251189,251189,251189,251190,252190,251190,250190,250. Neither the L.m. burden 
nor the localization of L.m. with CD11b+ cells in the MLNs were affected in the absence 
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of PPs compared to controls (Figure 12B-C). Thus, although PPs acquired L.m. from 
the intestinal lumen, and served as an antigen presentation site, they were dispensable 
for L.m. dissemination from the intestine following oral infection. 
 
L.m. disseminated to MLNs through the subcapsular sinus and the interfollicular 
zones   
To further examine the anatomical events surrounding intracellular trafficking of L.m. to 
the MLNs, we analyzed in depth the architecture of the early immune response to L.m. 
using confocal microscopy. At 24hrs following oral infection, L.m. were detected in the 
SCS of MLNs (Figure 14A-B), apposed to CD169+ SCS macrophages, some of which 
expressed CD11b (Figure 14A-B). In addition, L.m. were closely associated with Lyve-
1+ lymphatics that are associated with the SCS (Figure 14C), but not with lymphatics 
elsewhere in the MLN (Figure 14C). Ly6G+ polymorophonuclear neutrophils (PMN) 
were always found coincident with L.m., even in the SCS (Figure 14D). By 48hrs after 
infection, L.m. could be seen entering through multiple interfollicular zones (Figure 15). 
These areas are major sites of DC influx from the afferent lymph183 and contain innate-
like lymphocytes, including NK cells, NK-T cells and γδ T cells to presumably mount 
rapid innate responses182. Also at this time, L.m. were located in clusters in the deeper 
cortex in the T cell areas and were invariably associated with CD11b+ cells (Figure 15A-
C) that were Ly6G+ PMN (Figure 15D-F). T cells were excluded from these clusters that 
were surrounded by CD11c+ cells (Figure 15B-C). At 72hrs after infection L.m. were 
readily visualized in the MLN and PMN clustering continued to be evident (Figure 16B). 
Interestingly, we noted that PMN/L.m. clusters were surrounded by a zone of CD103+ 
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CD11c+ DCs (Figure 16), suggesting a potential antigen presentation location (Figure 
15C and 16). Histologically, L.m. were visualized in the interfollicular and the T cell 
zones up to at least day 5 after oral infection (Figure 17). Thus, L.m. disseminated to 
the SCS, and then spread through the interfollicular zones to converge in the T cell 
zone, surrounded by T cells and CD103+ DCs. 
 
Neutrophils are dispensable for bacterial clearance in the gut mucosa during both 
primary and secondary L.m. oral infection 
Earlier studies of neutrophil function during L.m. infection were confounded by the use 
of a Gr-1-specific mAb (RB6-8C) that depleted both neutrophils (CD11b+Ly6G+) and 
inflammatory monocytes (CD11b+Ly6ChiCCR2+)269,270. More recent work utilized 
neutrophil-specific depletion with an anti-Ly6G mAb, 1A841. The latter studies show that 
after i.v. infection neutrophils are important in clearance of L.m. from the liver but not 
from the spleen, while inflammatory monocytes are essential for overall early L.m. 
clearance41. Considering the colocalization of PMN with L.m. in the MLN that we 
observed (Figures 14-16), we tested the role of neutrophils in L.m. clearance after oral 
infection.  Depletion of PMN had little effect on bacterial clearance in the MLN, spleen or 
small intestine but did result in partial loss of clearance from the liver (Figure 18A). In 
contrast, depletion of both PMN and inflammatory monocytes resulted in massive 
overgrowth of L.m. in all tissues. Similar results were obtained after secondary infection 
with a 10-folder higher inoculation dose (Figure 18B).  
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We also examined the anatomical outcome of PMN or PMN+monocytes depletion after 
primary infection. Interestingly, when neutrophils were depleted, the thickness of the 
CD169+ SCS macrophage layer was substantially increased and this effect was even 
more dramatic when both PMN and monocytes were depleted (Figure 19) where we 
observed spreading CD169+ macrophages into the cortical areas where L.m. were 
clustered.  These data could potentially be explained by reduced clearance of infected 
CD169+ macrophages by neutrophils271, or by enhanced migration of CD169+ 
macrophages in the absence of neutrophils and monocytes in response to increased 
bacterial burden.  
 
Batf3-dependent DCs are required for L.m. but not Salmonella dissemination after 
oral infection   
Since L.m. were shuttled to the MLNs intracelluarly (Figure 10A), we studied which cell 
type was involved in this process. Previous studies show that CD8α+ DCs are involved 
in movement of blood-borne L.m. into the splenic marginal zone after i.v. infection25,198. 
In the skin, lung and intestinal mucosa, CD103 expression marks migratory DCs 
183,186,211 and thus CD103+CD8α+ DCs are potentially involved in shuttling L.m. from 
intestine to MLNs. In mice lacking the transcription factor Batf3, CD11b-CD103+ DCs 
(mainly composed of CD8α+ DCs) are absent in the intestinal lamina propria (LP) at 
steady state196. However, these Batf3-dependent DCs re-appear after 9 weeks of M. 
tuberculosis infection200 and their absence is also strain dependent272. Therefore, we 
examined the status of CD11b-CD103+ DCs in Batf3-/- mice on day 2 after oral L.m. oral 
infection. While the CD11b+ CD103+ DCs were present in the MLNs, PPs and LP of 
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infected Batf3-/- mice, the CD103+CD11b- subset was absent (Figure 20). Moreover, two 
days after oral infection, the presence of L.m. was significantly reduced as shown by 
confocal microscopy (Figure 21A), and three days after oral infection L.m. colonization 
of the MLNs in Batf3-/- mice was decreased ~10-fold as compared to wild type Balb/c 
control mice (Figure 21B). However, when mice were orally infected with Salmonella 
typhimurium, the bacterial burden in the MLNs of Batf3-/- mice was equivalent to that of 
control mice (Figure 21C). Thus, Batf3-dependent DCs were required for L.m. 
dissemination, and this requirement was not universal for all bacteria. 
 
Batf3-dependent DCs shuttle non-replicative L.m. from intestine to MLN 
The preference for Batf3-dependent DCs by L.m. but not by Salmonella led us to 
address the mechanism underlying this requirement. Previous studies using i.v. L.m. 
infection proposed that CD8α+ DCs may supply an environment that allows L.m. 
survival and replication, thus providing the initial niche for L.m. dispersion23-25. 
Alternatively, or in addition, a receptor based mechanism could be involved in 
acquisition of L.m. by DCs. To test these possibilities, we fed Batf3-/- mice or wild type 
control mice with 4x109 cfu of irradiated L.m., which are immunogenic but are non-
replicative273,274. Six and twenty two hours after IRL administration to WT or Batf3-/- mice, 
IRL were quantitated in the MLNs using confocal microscopy (Figure 22A-F). 
Interestingly, while IRL were readily detected in the subcapsular and interfollicular areas 
of MLNs from WT mice, few IRL were present in MLNs of Batf3-/- mice (Figure 22A-B, E-
F). These results indicated that while Batf3-dependent DCs may provide a replicative 
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niche for live L.m., they were also essential for dissemination of non-replicative L.m.  
suggested a receptor-mediated mechanism. 
 
IV. Conclusion and Discussion 
Our study focused on L.m. dissemination and the corresponding immune responses 
occurring in the intestinal mucosa after oral infection. Initially, L.m. infection was limited 
to the intestine and MLNs, and antigen presentation occurred predominantly in PPs and 
MLNs rather than the spleen, which is the primary antigen presentation site following i.v. 
L.m. infection.  Although L.m. were efficiently transported into PPs, we demonstrated 
that PPs were dispensable for L.m. dissemination from the intestine to internal tissues.  
However, mice lacking PPs still retain M cells275 and thus these cells could potentially 
participate in bacterial transport across the epithelium.   
 
The kinetics of L.m. propagation in different tissues was compatible with the location 
and persistence of antigen presentation, indicating a potential association between the 
dissemination of live bacteria and antigen presentation occurring in a particular site. L.m. 
entered MLNs carried intracellularly through lymphatics into the interfollicular zones, 
identifying a potential anatomical niche for the initiation of immune responses against 
L.m. invasion. DCs and viruses also enter into LN through the interfollicular zones184. 
The interfollicular zones are prepositioned with a network of IFNγ-producing innate-like 
lymphoid cells182, and IFNγ is a critical cytokine for the activation and maturation of 
inflammatory monocytes to TipDCs and the initiation of immune responses during L.m. 
infection in the spleen40. In addition, both primary and secondary T cell priming can 
75 	  	  
occur in the interfollicular zones of peripheral LN after virus infection184,276. In our case 
with oral L.m. infection, the reorganization of CD103+ DCs and CD8 T cells into discrete 
areas surrounding L.m.-neutrophil clusters may provide zones for promotion of T cell 
and DC interaction to initiate priming.  Future studies will assess the anatomy and the 
kinetics of antigen presentation and T cell activation in the mucosa in response to oral 
infection. 
 
The appearance of L.m. in the MLNs was invariably coincident with clustering of Ly6G+ 
neutrophils, suggesting that neutrophils were intimately involved in the early innate 
immune response against L.m. infection. However, in agreement with previous studies 
examining bacterial clearance in the spleen during i.v. L.m. infection41, neutrophils were 
dispensable for L.m. clearance in the gut mucosa, although the absence of neutrophils 
resulted in partial loss of clearance in the liver as previously noted42. For both i.v. and 
oral L.m. infections, inflammatory monocytes were essential for bacterial clearance thus 
begging the question what is the precise role of neutrophils in the response.  One 
possibility is that in the absence of neutrophils, other cells can efficiently compensate for 
their functions. It should also be noted that neutrophils are in fact important for 
protection against systemic L.m. infection when high doses of bacteria are 
administered42.  In our studies, depletion of neutrophils was not without effect, as we 
observed an enhanced infiltration of CD169+ macrophages the T cell zone of the MLN, 
suggesting a potential compensatory role for these cells that are known to be involved 
in bacterial clearance in the spleen24 and can also cross-present tumor antigens in the 
LN277. This effect was dramatically enhanced when both neutrophils and monocytes 
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were depleted, although in that case bacterial burden was substantially increased. 
Nonetheless, these results indicated that CD169+ subcapsular sinus macrophages can 
respond to L.m. infection, although there precise function remains unknown. An 
additional possibility is that neutrophils are involved in removal of L.m.-infected CD169+ 
macrophages, similar to what occurs during T. gondii infection271. Further in-depth 
studies will be required to decipher the complex interplay between the numerous cell 
types involved in the early response responsible for decreasing bacterial burden after 
oral infection. 
 
CD103+ DCs are migratory DCs in the intestinal mucosa186 and previous work shows 
that early after i.v. L.m. infection, bacteria preferentially reside in splenic CD8α+ DCs23,26.  
Thus, Batf3-dependent DCs (CD11b-CD103+ DCs) are migratory DCs that may provide 
a survival niche for L.m. However, the precise mechanism by which CD8α+ DCs 
preferentially acquire L.m. is not known. Our results indicated that Batf3-dependent DCs 
were required for carriage of both live and non-replicative irradiated L.m.. Thus, Batf3-
dependent DCs may not be essential for initial bacterial growth but were required for 
bacterial transport. This process is likely to be receptor mediated since the gram-
negative bacterium S. typhimurium efficiently disseminated from intestine to MLN in 
Batf3-deficient mice.  Thus, it is possible that Batf3-dependent DCs are critical for the 
phagocytosis of Gram+ but not Gram- bacteria. Scavenger receptors may be involved in 
this process50. During i.v. infection, complement C3 mediates platelet association 
between various Gram+ bacteria including L.m.23. The interaction of platelets and C3 
protects L.m. from phagocytosis by macrophages in the blood and is required for CD8α+ 
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DCs recognition in the spleen23. It is unknown whether L.m. dissemination in the gut 
mucosa utilizes a similar mechanism. Interestingly, complement may have a general 
role in the DC migration considering a recent report showing that CD103+ DCs in lung 
mucosa exclusively produce high levels of complement C3 and C5 during influenza 
infection that is essential for their migration to the draining LN278. Whether L.m. or Batf3-
dependent intestinal DCs may interact with complement components and/or platelets 
remains to be seen.  
 
In sum, our findings demonstrated a unique pattern of L.m. dissemination from the 
intestine to MLNs via intracellular shuttling by Batf3-dependent DCs likely via receptor-
mediated phagocytosis, leading to the coordinated architectural reorganization of innate 
immune cell components focused on local control of the bacterial infection. 
 
 
  
78 	  	  
V. Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Infection is limited in gut at 24hrs following oral infection.  L.m. burden in 
MLN, small intestine (SI), liver (LV) and spleen (SP) from day 1 to 8 after oral infection. 
Female Balb/cJ mice were orally fed with 2x109cfu lnlAm-L.m.(10403s). MLN, small 
intestine, liver and spleen were harvested on day 1, 2, 3, 5, 8 after the consumption of 
L.m.-loaded bread. Each dot/solid line represents the mean ± 1 SEM. These data are 
representative of two independent experiments, each containing five mice per group. 
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Figure 10. L.m. disseminate into MLN intracellularly. L.m. burden in A, MLN and B, 
liver of control or gentamicin-treated mice on day 3 after oral infection. Female balb/cJ 
mice were orally fed with 2x109 cfu lnlAm-L.m.(10403s) oral infection. 4hrs after oral 
infection, 1mg gentamicin was s.c. injected to the infected mice. L.m. burden was 
evaluated on day 3 after infection. Statistical significance was determined by Mann-
Whitney test: *p < 0.05, ns=non significant. Each dot/solid line represents the mean ± 1 
SEM. These data are representative of two independent experiments, each containing 
five mice per group. 
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Figure 11. Antigen presentation sites and duration in gut mucosa after L.m. oral 
infection. A, 1x106 CFSE labeled CD45.1 OTI cells were transferred i.v. into CD45.2 
hosts that were either orally infected 1 day earlier or were naive. 16hrs later cells from 
MLN, PP, and spleen of infected (red histogram) or naive (grey histogram) mice were 
cultured for 3 days and analyzed for CFSE dilution.  The number within histograms 
represents the percentage of OTI, which did not dilute CFSE from infected mice. The 
histograms are representative of data from three experimental mice. b. CFSE labeled 
CD45.1 OTI cells were transferred i.v. into CD45.2 mice on day 3, 6, 10, or 14 after oral 
L.m. infection. Cells from indicated tissues were harvested 3 days after transfer and 
assessed for CFSE dilution. The percentage of OTI, which did not dilute CFSE, is 
reported as percent undivided. Values represent the mean ± SEM. Each point 
represents three mice. 
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Figure 12. PPs are dispensable for L.m. dissemination to MLN. A, One day after 
oral L.m. infection, PP cryosections were stained to identify L.m. (red), B220 (green), 
and CD8β (blue). Bar represents 200µm. Image is representative of two independent 
experiments. B, Bacterial burden in MLNs and liver (LV) of control mice and PP-
deficient mice was evaluated 3 days after oral L.m. infection.  Statistical significance 
was determined by Mann-Whitney test. n.s. for non significant when p>0.05. Each solid 
line represents the mean ± SEM. Data are representative of two independent 
experiments, each containing five mice per group. c. Imaging of control mice and PP-
deficient mice 3 days after oral infection. MLN cryosections were stained to identify L.m. 
(white), CD3e (yellow), CD11b (blue), and B220 (magenta).  Legend bar represents 
200µm. Images are representative of two independent experiments. 
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Figure 13. Negative control for L.m. staining on MLN of control naïve mice. MLNs 
of Balb/cJ mice were harvested 3 days after oral L.m. infection. Cryosections were 
stained to identify L.m. (red), CD8α (green), and CD11b (blue). Legend bar represents 
100µm. This image is a representative of two independent experiments. 
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Figure 14. L.m. localize to the 
subcapsular region of the MLN 
early after oral infection. A-B,  
Initial entry of L.m. into the 
subcapsular sinus of MLN 1 day 
after oral infection. MLN sections 
were stained to identify L.m. (white), 
CD169 (MOMA-1, red), and CD11b 
(blue). L.m. staining was 
highlighted with white spheres 
using Imaris software. C-D, Three 
days after oral L.m. infection 
cryosections of MLN were stained 
to identify L.m. (red), Lyve-1 
(yellow), B220 (green), and Ly6G 
(blue).  Bar represents 50µm (A,B) 
or 200µm (C,D). Images are 
representative of two independent 
experiments. 
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Figure 16. L.m. disseminate to the 
MLN via the interfollicular zones 
followed by localization in the T 
cell zones. A-C, MLNs from 
C57BL/6 mice were harvested 2 
days after oral L.m. infection. MLN 
cryosections were stained to identify 
L.m. (magenta), CD11c (yellow), 
CD11b (blue), B220 (green), and 
CD3e (red). L.m. staining was 
highlighted with magenta spheres 
using Imaris software. Bar 
represents 200µm. Images are 
representative of at least three 
independent experiments. D-F, 
MLNs from Balb/cJ mice were 
harvested 2 days after oral L.m. 
infection. MLN cryosections were 
stained to identify L.m. (green), 
CD11b (blue), and Ly6G (red). 
Legend bar represents 200 µm. 
Images are representative of at least 
three independent experiments.  
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Figure 17. Cellular reorganization 
of MLN after oral L.m. infection. 
CD103+ DCs surround infection foci 
in the MLN 3 days after oral L.m. 
infection. MLNs of C57BL/6 mice 
were harvested 3 days after oral 
L.m. infection. Cryosections were 
stained to identify L.m. (green), 
CD11c (blue), CD103 (red), and 
CD11b (white). Bar represents 
200µm. Images are representative 
of three independent experiments. 
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Figure 18. Presence of L.m. in MLN on day 5 after oral infection. MLNs of C57BL/6 
mice were harvested 5 days after oral L.m. infection. MLN cryosections were stained to 
identify L.m. (white), CD11c (yellow), CD11b (blue), and CD3e (red).  Legend bar 
represents 200µm. This image is representative of two independent experiments. 
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Figure 19. Neutrophils are dispensable for L.m. clearance during primary or 
secondary oral infection. A, Balb/cJ mice were orally fed L.m.. Infected mice were 
treated on days -1, 0, 1, and 2 with anti-Ly-6G (1A8) to deplete neutrophils, with anti-Gr-
1 (RB6-8C) to deplete neutrophils and monocytes, or with isotype control antibodies. 
L.m. burden of neutrophils or neutrophils+monocytes depleted mice during primary 
infection. Female Balb/cJ mice were orally fed with 2x109 cfu lnlAm-L.m.(10403s). 
Neutrophils or neutrophil+monocytes of the infected mice were depleted using anti-
Ly6G (1A8) mAb or anti-Gr-1(RB6-8C) respectively. MLN, small intestine (SI), liver (LV) 
and spleen (SP) of mAB were harvested on day 2 after oral infection. B, L.m. burden of 
neutrophils or Neutrophils+monocytes depleted mice during secondary infection. 
Memory mice were orally fed with 2x1010 cfu lnlAm-L.m.(10403s) as secondary infection. 
Infected mice were treated on days -1, 0, 1, and 2 with anti-Ly-6G (1A8) to deplete 
neutrophils, with anti-Gr-1 (RB6-8C) to deplete neutrophils and monocytes, or with 
isotype control antibodies. Indicated tissues were harvested on day 2 after secondary 
infection. Statistical significance was determined by Mann-Whitney test. *p<0.05, 
**p<0.01, n.s. for non significant when p>0.05. TNTC, to numerous to count.  Each solid 
line represents the mean ± 1 SEM. 
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Figure 20. CD169+ macrophages mobilize towards the T cell zone following anti-
Ly6G or Gr-1 depletion. Balb/cJ mice were orally fed L.m.. Infected mice were treated 
on days -1, 0, 1, and 2 with anti-Ly-6G (1A8) to deplete neutrophils, with anti-Gr-1 (RB6-
8C) to deplete neutrophils and monocytes, or with isotype control antibodies. Two days 
after infection, MLNs were harvested and sectioned. Cryosections were stained to 
identify CD169/MOMA-1 (green). Legend bar represents 200 µm. Images are 
representative of two independent experiments. The thickness of CD169+ area was 
measured by Imaris. 25 measurements were applied within non-medulla or medulla 
area (the start and the end of the medulla area taking into account was marked by the 
red arrows) of MLN respectively. Statistical significance was determined by one-way 
ANOVA test. ***p<0.001. 
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Figure 21. CD11b-CD103+DCs are absent in Batf3-/- mice after L.m. oral infection. 
MLNs, PPs, and LP from wild type and Batf3-/- mice were harvested 2 days following 
oral L.m. infection. CD11C+ MHCII+ DCs were analyzed for CD11b and CD103 
expression. Data are representative of two independent experiments, each containing 4 
- 5 mice per group. 
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Figure 22. Batf3-dependent DCs shuttle L.m. but not Salmonella to the MLNs after 
oral infection.  A, MLN from wild type or Baft3-/- mice were harvested 2 days after oral 
L.m. infection.  MLN cryosections were stained to identify L.m. (red) and Ly6G (blue). 
Legend bar represents 200µm. B, Bacteria burden was quantified from the MLN of wild 
type or Baft3-/- mice 3 days following oral L.m. infection. C, Bacterial burden was 
quantified in the MLN, spleen (SP), and liver (LV) of wild type or Baft3-/- mice 4 days 
following oral Salmonella infection. Statistical significance was determined by Mann-
Whitney test. *p<0.05, n.s. for non significant when p>0.05.  Each solid line represents 
the mean ± SEM. Data are representative of two independent experiments, each 
containing 5-6 mice per group. 
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Figure 23. Batf3-dependent DCs are required for the dissemination of irradiated 
L.m. to the MLN. A-B, MLN from wild type or Baft3-/- mice were harvested  6hr after 
gavage of 4x109 IRL. Sections were stained to identify L.m.(white) and CD11c (blue). 
L.m. staining was highlighted using white spheres.  Bar represents 200µm. These 
images are representative of at least three independent experiments, each containing 2 
mice per group. C-D, Quantification of IRL in MLN of wild type or Baft3-/- mice at 6 (C) 
and 22 (D) hours after oral IRL administration. IRL from multiple sections of comparable 
thicknesses were counted. #1-#4 in C indicate different sections analyzed from one 
representative experiment of the three independent experiments, and #1-#2 in D 
indicate different sections analyzed from two independent experiments. E-F, L.m. 
staining of images in A and B without imaris highlight. Bar represents 100µm. 
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VI. Summary Figure 
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CHAPTER 5 
 
CONCLUSION AND DISSCUSSION 
The goal of the study described in this thesis is to analyze both innate and adaptive 
immune responses to L.m. infection. We found a potential new pathway for PD-L1 
costimulation of the CD8 T cell response to L.m. infection. Meanwhile, as the natural 
infection route of L.m. is through ingestion, we analyzed L.m. dissemination pattern and 
the subsequence innate immune responses following oral infection. We identified an 
organized innate immune response to an orchestrated pattern of Listeria dissemination 
in the intestinal mucosa.	  
 
The role of PD-L1 in the adaptive immune response to L.m. infection 
L.m. elicits robust T cell responses and complete clearance of L.m. requires the effort 
from CD8 T cells. Optimal CD8 T cell responses require CD4 T cell help, costimulation, 
and proper cytokine environments. Previous study has shown that L.m. infection 
generates different inflammatory environment than VSV infection54.  As a result, L.m. 
infection gives rise to enhanced differentiation of short-lived effector cell than VSV 
infection54. The short-lived effector cells have shorter life span than the memory 
precursors and undergo significant apoptosis during contraction phase of CD8 T cell 
responses56,57. The differentiation of short-lived effector cells are affected by cytokine 
environments and controlled by transcription factor including T-bet and Blimp-154,57,64,65. 
PD-1 on CD8 T cells has been studied mostly as an inhibitory molecule inhibiting TCR 
signaling during acute infection and leading to apoptosis and exhaustion during chronic 
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infection279. Thus, interrupting PD-1 interaction with PD-L1 improves CD8 T cell 
responses during most of the infections157,161,279. However, a few reports showed that 
PD-L1 deficiency leads to impaired CD4 T or CD8 T cell responses in Salmonella, 
Listeria infection models or mouse colitis model171,172,175. Thus we ask what are the 
factors determining PD-L1 positive activation role in CD8 T cell responses, whether PD-
L1 costimulation on CD8 T cell response during L.m. infection is dependent on CD4 T 
cell help, whether PD-L1 costimulation affects CD8 T effector differentiation, and 
whether PD-L1 acts differently when inflammatory environments are different. 
 
It is unknown that what are the factors determining PD-L1 costimulatory effect versus 
inhibitory effect on CD8 T cells. We found that PD-L1 blockade using mAb 10F.9G2 
impaired endogenous antigen-specific CD8 T cell responses to L.m. but not VSV 
infection. Considering that L.m. infection generates enhanced IL-12-mediated signals 
than VSV54, one hypothesis is that: inflammatory environment is one of the factors that 
determine PD-L1 costimulation effect on CD8 T cells. PD-L1 expression is upregulated 
after infection with either L.m. or VSV. Supporting this hypothesis, VSV induced lower 
PD-L1 expression level on CD8 T cells compared to L.m. infection. Thus there might be 
a threshold for PD-L1 expression level that to allow it binding to the unknown 
ligand/epitope to be costimulatory or vice versa. One the other hand, the inflammatory 
environment may also regulate the expression of the unknown ligand. IL-12 has been 
shown to increase PD-L1 expression on epithelial cells, monocytes and T cells280,281. It 
is possible that during VSV infection, additional IL-12 treatment might enhance PD-L1 
expression level on CD8 T cells and as a result PD-L1 might show the same positive 
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effect on CD8 T cell responses as it is in L.m. infection. Another report has shown that 
PD-L1 costimulation on CD8 T cell is dependent on innate IFNγ during early infection259, 
and the expression of the innate IFNγ can be abolished in mice deficient for both IL-12 
and type I IFNs. In this report, IL-12 and type I IFNs plays compensatory roles as only 
double-blockade of both negates PD-L1 costimulation effect on CD8 T cells. This report 
also supports the hypothesis that inflammatory environment is one of the factors that 
determine PD-L1 costimulation on CD8 T cells. The expression or exposure of the 
unknown ligand/epitope is also important for the modulation of PD-L1 costimulation 
effect. IL-12 or type I IFNs may also affect the expression of the unknown ligand/epitope. 
When PD-L1 blockade didn’t enhance the expansion of antigen-specific IFNγR-deficent-
CD8 T cells following L.m. infection, indicating that there are other factors determining 
the costimulatory effect versus inhibitory effect of PD-L1.  
 
In addition, we showed that specific interruption of PD-L1 interaction with PD-1 or/CD80 
did not recapitulate PD-L1 blockade effect on CD8 T cells, and a reduced antigen-
specific CD8 T cell population when blocking PD-L1 on the basis of PD-1 blocking. The 
results indicate an unknown receptor binding to PD-L1 for the costimulatory function. 
However Rowe, et al proposed that PD-L1 costimulation via PD-1:PD-L1 interaction, as  
antigen-specific PD-1-deficient-CD8 T cells were not reduced after PD-L1 blockade259. It 
is possible that the mAb we used for PD-1 blockade only blocks the epitope for the 
inhibitory function of PD-1, while the PD-L1 costimulation acts by PD-L1 binding to a 
novel epitope that is not recognized by the mAb (RMP1-14). On the other hand, 
although Rowe, et al didn’t observe a reduction of antigen-specific PD-1-deficient-CD8 
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T cells with anti-PD-L1 blockade, the population of antigen-specific PD-1-deficient-CD8 
T cells without anti-PD-L1 blockade were not decreased either, which is compatible with 
our anti-PD-1 blockade result. Thus another possibility is that PD-1 is required for the 
expression of the unknown ligand.  
 
For L.m. i.v. infection, both CD4 T cells and CD8 T cells contribute to bacteria clearance. 
CD4 T cells provide helps to CD8 T cell priming and differentiation59. Different from the 
impact of PD-L1 on CD8 T cells, we did not observe impaired antigen-specific CD4 T 
cell expansion with PD-L1 blockade, although PD-L1 expression was increased on both 
CD4 T cells and CD8 T cells after L.m. infection. Unaltered antigen-specific CD4 T cell 
population in PD-L1 blockade group indicated that the impaired antigen-specific CD8 T 
cell response is not an indirect consequence of inadequate CD4 T cell help. We also 
confirmed that the impact of PD-L1 on CD8 T cells operated independent of CD4 T cell 
response, by blocking PD-L1 and depleting CD4 T cells simultaneously. This approach 
also indicated that the impact of PD-L1 on CD8 T cells was not due to an indirect impact 
through regulatory T cells. Both CD4 T cells and CD8 T cells upregulate PD-L1 after 
infection. However, CD4 T cell population was not affected with PD-L1 blockade. The 
expression profile of the unknown ligand/epitope may explain the different impact of PD-
L1 on CD4 T cells and CD8 T cells. It is possible that the unknown ligand/epitope are 
preferentially expressed on antigen presenting cells priming CD8 T cells versus CD4 T 
cells. In the future, the expression profile of the unknown PD-L1 ligand/epitope needs to 
be studied in the context with inflammation environment influencing PD-L1 costimulation 
effect. 
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In future studies, conditional knockout of PD-L1 in CD8 T cells could be used to confirm 
the intrinsic role of PD-L1 in CD8 T cell activation. It is still not known the impact of PD-
L1 costimulation is through T cell-T cell interaction or T cell-DCs/Macrophages 
interaction. Our data indicated that PD-L1 was transiently upregulated on both T cells 
and DCs/macrophages following L.m. infection. Thus, it could be the unknown 
ligand/epitope expressed on DCs/macrophages binding to PD-L1 expressed on CD8 T 
cells or vice versa. T cell-T cell interaction is also possible but as effect of PD-L1 
blockade is CD4 T cell independent, it should not be CD4 T-CD8 T interaction. To test 
the above possibilities, conditional knockout of PD-L1 in CD8 T cells need to be 
analyzed in L.m. infection in compared with PD-1 conditional knockout CD8 T cells and 
wild type control in the same infected mouse.  
 
Costimulatory molecules are highly redundant and act flexibly. Which pairs are critical 
under what conditions has not been clarified. With the different impact of PD-L1 on CD8 
T cells during L.m. infection and VSV infection, we propose that the inflammatory milieu 
may play some role in the mechanism of tuning costimulation. The different 
inflammatory environment may contribute to a different expression profile of 
costimulatory molecules or their corresponding ligands/receptors. Thus, identifying the 
ligand for PD-L1 would provide great insight into understanding why the impact of PD-
L1 costimulation preferentially occurs for CD8 T cells while PD-L1 is upregulated on 
both CD4 T cells and CD8 T cells after activation. It is possible that the corresponding 
ligand for PD-L1 costimulation is predominantly expressed on APCs that prime CD8 T 
cells. Also, in the future, the required inflammatory environment influencing PD-L1 
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costimulatory versus inhibitory effects should be investigated in the context of the 
expression of the unknown PD-L1 ligand. 
 
Both PD-1 and PD-L1 antagonist mAbs are studied in the clinical trials for cancer 
therapies282-284. The combination of anti-CTLA-4 and PD-1 mAb has been shown 
promising therapeutic effect in cancer and infection than anti-CTLA-4 alone285,286. 
Therefore, studies about PD-L1 interaction with different binding partners in different 
inflammatory milieu might provide more insights for the antagonist mAbs therapies. 
Meanwhile, the therapy of anti-PD-1 and anti-CTLA-4 dual blocking in the combination 
of vaccine has shown improved efficacy in caner than mAbs or vaccine treatment alone 
in mouse model287. Thus, in the future it might be worthwhile to study the role of PD-L1 
antagonist mAb in cancer-antigen specific CD8 T cell response when the mAb is 
applied in combination with recombinant Listeria-vaccine. Also, whether PD-L1 
costimulation also applies to human CD8 T cells need to be analyzed. 
 
The mucosal immune response to oral lm infection 
Knowledge about L.m. dissemination and subsequent immune responses is beneficial 
for the development of L.m.-based vaccines as potential therapies for cancer and 
infections like HIV. Many of the previous studies of Listeria infection have been 
accomplished using an i.v. injection mouse model. The natural infection route for L.m. is 
via ingestion of contaminated food. Thus, L.m. could serve as a great oral vaccine 
vector that induces local immune responses and protects the local mucosa from the 
invasion of pathogens. Protective effects have been identified in cats that have been 
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orally immunized with an L.m. vaccine after vaginal challenge with feline 
immunodeficiency virus20. However the dissemination of L.m. in the gut mucosa and 
subsequent induction of immune responses have not been characterized. Thus, we 
studied L.m. dissemination and related immune responses in the gut mucosa of mice 
using an oral infection model. We used oral feeding instead of the traditional gavage 
method to apply oral infection. This oral feeding method best mimicked the natural route 
of L.m. infection. Compared to gavage, the possibility of microvasculature breaks to 
inadvertently induce systemic infection is avoided using this method. 
 
In humans but not mice, lnlA expressed by wild type L.m. binds to E-cadherin to 
mediate infection of intestinal epithelial cells202,262. To best mimic oral L.m. infection in 
humans, we utilized an InlA mutant201 L.m. to allow the bacteria to cross the intestinal 
barrier through both the epithelium and PPs in mice. 2X109 cfu  L.m.-lnlAm was applied 
for oral infection. This infection dose is comparable to 1X103 cfu L.m. i.v. infection in 
mice, and Listeria infection dose for human patients201,288. For L.m. i.v. infection, L.m. 
arrives in spleen within a few minutes and disseminates to T cell zones for antigen 
presentation within 24hrs26. For oral infection, L.m. dissemination to the MLN appeared 
slower, although antigen presentation occurred in the MLN at least as early as 24hrs 
after infection. Thus, antigen was likely transported by migrating APC from the LP or 
PPs prior to the arrival of bacteria in the MLN or the very early wave of L.m. are 
instantly cleared once arrive MLNs. After leaving the intestine, L.m. is first propagated in 
MLNs, and bacterial burden peaked on ~dpi2-3. Antigen presentation occurred in both 
MLNs and PPs on dpi1 but not in spleen, which is the main antigen presentation site for 
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i.v. infection. The duration of antigen presentation is compatible with bacteria burden 
kinetics in different tissues. Using confocal microscopy we could observe L.m. presence 
in MLNs up to dpi5, although that was the last day of analysis.  L.m. disseminated to 
MLNs intracellularly as gentamicin treatment did not reduce bacterial burden in MLNs, 
while the treatment impaired bacterial dissemination to the liver in the same mice. This 
result indicates that L.m. was shuttled to MLNs intracellularly but its dissemination to 
liver involved extracellular spread, probably via the blood stream. Although L.m. entered 
into the PPs, systemic dissemination of L.m. did not require PPs. M cells still exist in the 
PP-deficient mice generated by anti-IL-7R mAb275, so M cell could still acquire L.m. from 
the lumen. This result indicates a possibility that DCs from LP, or ILFs could assist L.m. 
dissemination. Also, ILFs could compensate to PP function in the PP-deficient mice.  
From the draining lymph, L.m. entered into MLNs via the interfollicular zones. These 
zones contain prepositioned innate lymphocytes that are able to quickly respond to 
pathogenic stimuli to produce IFNγ. Thus, entry of L.m. via interfollicular zones provides 
a niche for initiation of immune responses. Interfollicular zones are also proposed as 
CD8 T cell-priming sites during primary infections184, while other reports suggest that the 
T cell zone is the site for T cell priming during infection, while the interfollicular zone is 
the site for T cell priming during secondary challenge276. The priming site might be 
different from infection to infection, as different pathogens disseminate to antigen 
presentation sites differently. After passing through multiple interfollicular zones, L.m. 
accumulated in T cell zones surrounded by a band of CD103+ DCs and T cells. This 
profile indicates a potential antigen presentation site in response to   primary oral L.m. 
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infection. In the future it will be interesting to identify the location in the MLNs where 
primary and secondary CD8 T cell-priming occurs.   
 
Similar to what was observed in i.v. infection models41,42, neutrophils were dispensable 
for L.m. clearance in the gut during both primary and secondary L.m. oral infection. The 
role of neutrophil for L.m. clearance in tissues other than liver is still mysterious. It is 
mostly believed that neutrophils are not important for clearance of intracellular 
pathogens. However, we found that L.m. always associated with Ly6G+ neutrophils, 
indicating that neutrophils are probably intensely involved in the immune responses 
elicited by L.m.. The reason that neutrophils were dispensable might be explained by 
compensatory roles mediated by other cells. Many intracellular bacteria propagate in 
host cells, which leads to apoptosis of the host cells86,89. Thus, immune redundancy 
guarding against infection is beneficial for host defense against various infections. 
When we depleted neutrophils using anti-Ly6G mAb (1A842,223), we found an enhanced 
spreading of CD169+ macrophages into MLNs. Thus, CD169+ macrophages might be a 
candidate for providing compensation in the absence of neutrophils. 
 
Next we studied which cell shuttles L.m. intracellularly from intestine to MLNs. CD8α+ 
DCs are thought to be the 1st survival niche in the spleen for L.m. in the i.v. infection 
model. In addition, the splenic resident CD8α+ DCs are shown to be critical for the 
dissemination of L.m. from red pulp to PALS after i.v. infection. Thus we hypothesize 
that CD8α+ DCs are the host cells shuttling L.m. from intestine to MLNs. Development 
of CD8α+ DCs is dependent on the transcription factor Batf3. In the absence of Batf3, 
107 	  	  
CD8α+ DCs are absent in the spleen and also in the MLN, LP and PP in the steady 
state and after L.m. oral infection. In gut, Batf3-dependent DCs are described as 
CD11b-CD103+ DCs. This DC subset is mainly composed of CD8α+ DCs. Importantly, 
these DCs express CD103, which marks the DCs migrating from the intestine to the 
MLNs. Although both spleen and LP contain Batf3-dependent DCs, the splenic Batf3-
dependent DCs are resident DCs located in marginal zone, while LP Batf3-dependent 
DCs are migratory DCs from intestine to MLNs. Based on their migration potential and 
the feature of a survival niche of Batf3-dependent DCs, we hypothesize that Batf3-
dependent DCs are the cells that carry L.m. intracellularly from the intestine to the 
MLNs. Compared with wild type mice, Batf3-/- mice contained a significantly reduced 
L.m. burden after oral infection. This result indicated that Batf3-dependent DCs are the 
cells shuttling L.m. to MLNs. In combination with the data from gentamicin-treated mice, 
L.m. should be shuttled intracellularly from intestine instead of associated with Baft3-
dependent DCs on the cell surface. In MLNs, we observed that a circle of CD103+ DCs 
surrounded L.m. clusters in the T cell zone. These DCs may not be the carriers of L.m. 
to the MLNs, as the majority of them are not clustered directly with L.m. within MLNs. It 
is possible that the carrier cells undergo prompt apoptosis after transportation of L.m. 
into MLNs, as L.m. induces apoptosis of associated immune cells. As a result, the 
carrier cells may be difficult to find. Or, it is also possible that neutrophil may be 
removing of the L.m. infected Batf3-dependent DCs as it has been reported that 
neutrophils remove T.gondii infected CD169+ macrophages in MLNs271. Alternatively, it 
is also possible that when the original CD103+ DCs shuttle L.m. to MLNs, other cell 
types mediate further dissemination of L.m. within MLNs.   
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In addition, we also showed that with IRL oral immunization, when L.m. cannot replicate, 
Baft3-dependent DCs were still required for L.m. dissemination. Thus, Baft3-dependent 
DCs likely express certain receptors that are able to recognize L.m. and then shuttle 
them to intestine draining lymph nodes. Different from L.m. infection, Batf3-dependent 
DCs are dispensable for Salmonella dissemination. Both DCs and macrophages222,249.  
have been reported to shuttle Salmonella, thus intestinal macrophages or CD11b+ 
migratory DCs might compensate for the role of CD11b- migratory DCs when they are 
absent in Batf3-/- mice. Interestingly, although some of the IRL did arrive in the MLN, 
they only located in the SCS region of MLN. This result indicated that Batf3-dependent 
DCs might be required for further dissemination of L.m. into the MLNs, or further 
spreading of L.m. by other cell types may require cooperation with Batf3-dependent 
DCs. In the future, to study the dissemination of L.m. within MLNs, actA--lnlAm-L.m. 
could be fed to control and Batf3-/- mice to determine whether cell to cell spread is 
involved.  It is possible that Batf3-dependent DCs are only responsible for shuttling L.m. 
to SCS of MLNs, and that other cells, like CD169+ macrophages, drive further 
dissemination.  
 
Which receptor is responsible for recognizing L.m. is not known. Based on the different 
requirement for Batf3-dependent DCs, we hypothesized that the candidate receptor 
might preferentially recognize Gram-positive bacteria. In the i.v. infection model, the 
spreading of L.m. from blood to spleen requires platelet associated complement C3-L.m. 
complexes23. Both C3 complement and platelets are required in this mechanism. Thus, 
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the C3 receptor might also be another candidate receptor recognizing L.m., although 
C3aR is dispensable for L.m. spreading in the i.v. model. However, DCs migrate from 
intestine to MLNs via lymph, which is platelet poor, and thus L.m. acquisition by DCs 
after oral infection may not utilize a C3-mediated mechanism.  
 
Future studies aimed at identifying the L.m.-recognizing receptor on Batf3-dependent 
DCs are needed. Understanding the requirements for L.m. dissemination from the 
intestine may provide therapeutic targets for inhibiting systemic dissemination of various 
pathogenic organisms. In addition, as L.m. is a promising vaccine vehicle, knowledge of 
the mechanism of L.m. dissemination from the gut mucosa and the corresponding 
interactions with the mucosal immune system will greatly contribute to the rational 
design of mucosal vaccines for GI infections and cancer. 
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